Cosmetic composition comprising cell culture medium and albumin, and use thereof
A serum-free cosmetic composition using cell culture medium and albumin addresses safety and cost concerns by enhancing skin texture, transparency, and elasticity, and providing anti-inflammatory effects, effectively addressing skin irritation and inflammation.
Patent Information
- Application Number
- PCT/KR2024/006143
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-07-03
- Filing Date
- 2024-05-08
- Publication Date
- 2024-11-14
AI Technical Summary
The existing cosmetic compositions face challenges in providing safe, effective skin improvements without using fetal bovine serum, which poses safety concerns, animal protection issues, and high costs, while also requiring anti-inflammatory properties to address skin irritation and inflammation.
A cosmetic composition containing a serum-free cell culture medium and albumin as active ingredients, which improves skin conditions such as texture, transparency, moisturization, and elasticity, and provides anti-inflammatory effects by suppressing inflammatory cytokines like IL-6 and IL-8, while ensuring formulation stability and solubility.
The composition effectively improves skin texture, transparency, moisturization, and elasticity, while providing significant anti-inflammatory benefits, enhancing skin condition improvement efficiency and stability, and ensuring complete solubility of components without residues.
Smart Images

Figure KR2024006143_14112024_PF_FP_ABST
Abstract
Description
Cosmetic composition comprising cell culture medium and albumin and use thereof
[0001] The present invention relates to a cosmetic composition comprising a cell culture medium and albumin as active ingredients and its use.
[0002] The cells that make up skin are a type of animal cell, with keratinocytes and fibroblasts being representative examples. The general composition of the medium for culturing these cells includes Dulbecco's Modified Eagle's Medium (DMEM) and fetal bovine serum (FBS).
[0003] Serum is known to promote growth, provide nutrients, and protect cells from oxidation and toxins. When serum is excluded from cell culture, cell culture itself rarely occurs, and thus serum is recognized as an essential component for cell growth and proliferation. However, it has recently been reported that fetal bovine serum (FBS) may be the cause of human mad cow disease. This poses a threat to the safety of test subjects, and since serum is collected directly from fetal bovine fetuses, it poses a problem from an animal welfare perspective. Furthermore, FBS is expensive, which increases the cost of the medium.
[0004] Accordingly, there is a continuous demand for the development of compositions that are safe for the body and exhibit excellent effects in improving skin conditions such as skin texture, skin clarity, skin hydration, freckles, blemishes, and skin elasticity without containing FBS.
[0005] Against this backdrop, the present invention was completed by developing a cosmetic composition that is safe for the body and exhibits excellent effects in improving skin conditions such as skin texture, skin transparency, skin moisturizing, freckles, blemishes, and skin elasticity.
[0006] Meanwhile, existing hypoallergenic cosmetics for skin have been developed to avoid contact dermatitis and allergic dermatitis by eliminating potentially irritating active ingredients. However, environmental and psychological factors also require the use of active ingredients in cosmetics for those with sensitive skin.
[0007] In general, when looking at the mechanism of a stimulus response or inflammatory response, human keratinocytes or Langerhans cells produce and release various cytokines in response to external substances. These cytokines are substances that promote the activation of the immune system in the human body and are essential for inducing skin irritation or the progression of local inflammatory responses. Interleukin-6 (IL-6) and interleukin-8 (IL-8) are among the inflammatory cytokines, and when IL-6 or IL-8 is used, it is very easy to confirm whether the anti-inflammatory effect is implemented. Specifically, unlike other inflammatory cytokines, IL-6 or IL-8 are inflammatory genes that exist in human skin keratinocytes, and when irradiated with ultraviolet rays, the phosphorylation of the inflammatory factor regulatory protein nf-kB progresses (nf-kB pathway progresses), and the expression of interleukin-6 (IL-6) or interleukin-8 (IL-8) also increases. Therefore, if the expression level of IL-6 and / or IL-8 is confirmed after irradiating human skin keratinocytes with UV rays and the expression level is decreased after UV irradiation compared to before UV irradiation, it can be confirmed that the treated test substance promotes the self-defense mechanism of skin keratinocytes, thereby suppressing the expression of lipin-1 protein in the skin keratinocytes, thereby also suppressing the expression of the inflammatory genes IL-6 and / or IL-8. In other words, it can be confirmed whether the treated test substance is a substance for promoting the self-defense mechanism of skin keratinocytes.
[0008] In fact, increases in interleukin-6 (IL-6), interleukin-1 (IL-1), and tumor necrosis factor-α (TNF-α) have been reported in irritant contact dermatitis.
[0009] Against this backdrop, the present invention was completed by developing a cosmetic composition that is safe for the body and exhibits excellent effects in improving skin condition by alleviating inflammation.
[0010] In addition, the present invention was completed by identifying a method capable of increasing the solubility of the composition.
[0011] In addition, the present invention was completed by developing a technology capable of improving the stability of the formulation of the above composition.
[0012] In addition, the present invention was completed by developing a technique capable of promoting homogenization of the above composition.
[0013] One aspect provides a cosmetic composition comprising a cell culture medium and albumin as active ingredients.
[0014] Another aspect provides a composition for external application to the skin comprising a cell culture medium and albumin as active ingredients.
[0015] Another aspect provides an anti-inflammatory cosmetic composition comprising a cell culture medium and albumin as active ingredients.
[0016] Another aspect provides an anti-inflammatory skin external application composition comprising a cell culture medium and albumin as active ingredients.
[0017] Another aspect provides a composition comprising a cell culture medium, albumin, and a solubility enhancer.
[0018] Another aspect provides a method for improving the solubility of a composition comprising a cell culture medium and albumin, comprising the steps of: 1) dissolving components of a cell culture medium and albumin in a solvent; and 2) adding a solubility enhancer to the solution obtained in the above step and mixing the same.
[0019] Another aspect provides an oil-in-water cosmetic composition containing a cell culture medium and albumin as active ingredients while ensuring stability of the formulation.
[0020] Another aspect provides a composition for external application of skin in an oil-in-water form, which contains a cell culture medium and albumin as active ingredients and ensures stability of the formulation.
[0021] Another aspect provides a water-in-oil type cosmetic composition containing a cell culture medium and albumin as active ingredients while ensuring stability of the formulation.
[0022] Another aspect provides a water-in-oil type composition for external skin application containing a cell culture medium and albumin as active ingredients while ensuring stability of the formulation.
[0023] Another aspect provides a composite powder comprising a cell culture medium, albumin and a porous polymer.
[0024] Another aspect provides a method for producing a composite powder comprising a cell culture medium and albumin, comprising the steps of: 1) dissolving or dispersing a cell culture medium, albumin, and a porous polymer in a solvent; and 2) spray-drying the solution or dispersion.
[0025] Another aspect provides a composition comprising a composite powder comprising a cell culture medium, albumin, and a porous polymer.
[0026] One aspect is to provide a cosmetic composition comprising a cell culture medium, albumin, and a dissolution enhancer.
[0027] The term "cell culture medium" as used herein refers to a medium containing components required by cells for in vitro growth and survival, or components that aid cell growth and survival. Specifically, the components may include vitamins, essential or non-essential amino acids, and trace elements. The medium may be used for culturing cells, preferably eukaryotic cells, and more preferably animal cells.
[0028] Examples of the above cell culture medium include, but are not limited to, DMEM / F-12 (Dulbecco's Modified Eagle's Medium / Nutrient Mixture F-12), DMEM, MEMα (Minimum Essential Mediumα), BME (Basal Medium Eagle), GMEM (Glasgow Minimum Essential Medium), RPMI-1640 Medium, etc.
[0029] In addition, the cell culture medium of the present invention is a serum-free medium. A serum-free medium refers to a culture medium that does not contain serum derived from animals, including humans (e.g., animal-derived serum). Animal-derived serum provides general nutrients for the growth of cells to be cultured, but contains unidentified trace components, making analysis difficult, making it difficult to establish reproducible testing and production processes, and preventing safety for the human body from being guaranteed. However, the cell culture medium according to the present invention is a serum-free medium, ensuring safety for the human body and enabling the establishment of reproducible testing and production processes.
[0030] In addition, the above cell culture medium refers to a cell culture medium prior to culturing cells. Since it is a culture medium prior to culturing cells, there is no change in the components of the cell culture medium, so it can be used commercially with a homogeneous quality.
[0031] In one embodiment, the cell culture medium may include at least one selected from the group consisting of amino acid components, vitamin components, inorganic salt components, and other components, and may additionally include purified water.
[0032] The above amino acid component comprises at least one amino acid selected from the group consisting of glycine, L-alanine, L-valine, L-leucine, L-isoleucine, L-threonine, L-serine, L-cysteine, L-methionine, L-aspartic acid, L-asparagine, L-glutamic acid, L-glutamine, L-lysine, L-arginine, L-histidine, L-phenylalanine, L-tyrosine, L-tryptophan, L-proline, β-alanine, γ-aminobutyric acid, ornithine, citrulline, homoserine, triiodotyrosine, thyroxine and deoxyphenylalanine, and preferably, glycine, L-alanine, L-arginine, L-cysteine, L-glutamine, L-histidine, L-lysine, L-methionine, L-proline, It may comprise one or more amino acids selected from the group consisting of L-serine, L-threonine and L-valine.
[0033] The above vitamin component may include at least one vitamin selected from the group consisting of biotin, D-calcium pantothenate, folic acid, niacinamide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride, vitamin B12, choline chloride, i-inositol and ascorbic acid, and preferably, at least one vitamin selected from the group consisting of i-inositol, thiamine hydrochloride, niacinamide and pyridoxine hydrochloride.
[0034] The above inorganic salt component includes at least one inorganic salt selected from the group consisting of calcium chloride (CaCl2) (anhydrous), copper sulfate pentahydrate (CuSO4-5H2O), ferric sulfate heptahydrate (FeSO4-7H2O), magnesium chloride (anhydrous), magnesium sulfate (MgSO4) (anhydrous), potassium chloride (KCl), sodium chloride (NaCl), disodium hydrogen phosphate (Na2HPO4), sodium hydrogen phosphate monohydrate (NaH2PO4-H2O), zinc sulfate heptahydrate (ZnSO4-7H2O), ferric nitrate nonahydrate (Fe(NO3)3·9H2O), and sodium bicarbonate (NaHCO3), preferably sodium chloride (NaCl), sodium bicarbonate (NaHCO3), potassium chloride (KCl), calcium chloride (CaCl2) (anhydrous), and sodium bicarbonate. It may contain one or more inorganic salts selected from the group consisting of monohydrate (NaH2PO4-H2O).
[0035] The above other ingredients may include at least one other ingredient selected from the group consisting of D-glucose (dextrose), sodium pyruvate, hypoxanthine Na, thymidine, linoleic acid, lipoic acid, adenosine, cytidine, guanosine, uridine, 2'-deoxyadenosine, 2'-deoxycytidine HCl and 2'-deoxyguanosine, and preferably, may include sodium pyruvate.
[0036] The purified water is used to dissolve the amino acids, vitamins, mineral salts and other components, and may be water obtained through one or more distillations or purified through a filter.
[0037] In one embodiment, the cell culture medium may include glycine, L-alanine, L-arginine hydrochloride, L-cysteine hydrochloride-monohydrate, L-glutamine, L-histidine hydrochloride-monohydrate, L-lysine hydrochloride, L-methionine, L-proline, L-serine, L-threonine, L-valine, i-inositol, thiamine hydrochloride, niacinamide, pyridoxine hydrochloride, sodium chloride (NaCl), sodium bicarbonate (NaHCO3), potassium chloride (KCl), calcium chloride (CaCl2) (anhydrous), sodium bicarbonate monohydrate (NaH2PO4-H2O), and sodium pyruvate, and may be specifically composed of the above components.
[0038] The above amino acid component is used for cell growth as a raw material for protein synthesis, and it includes 0.2 to 1.2 parts by weight of glycine, 0.08 to 0.3 parts by weight of L-alanine, 2 to 7 parts by weight of L-arginine hydrochloride, 0.2 to 0.9 parts by weight of L-cysteine hydrochloride-monohydrate, 10 to 18 parts by weight of L-glutamine, 0.8 to 2.0 parts by weight of L-histidine hydrochloride-monohydrate, 1.0 to 5.0 parts by weight of L-lysine hydrochloride, 0.2 to 1.2 parts by weight of L-methionine, 0.2 to 1.2 parts by weight of L-proline, 1.0 to 5.0 parts by weight of L-threonine, and 1.0 to 5.0 parts by weight of L-valine, based on 1 part by weight of serine, an amino acid contained in the cell culture medium. Can be.
[0039] In one embodiment, the amino acid component and content included in the cell culture medium may be 0.5 to 1.0 parts by weight of glycine, 0.10 to 0.02 parts by weight of L-alanine, 5.0 to 6.0 parts by weight of L-arginine hydrochloride, 0.4 to 0.7 parts by weight of L-cysteine hydrochloride-monohydrate, 12 to 15 parts by weight of L-glutamine, 1.0 to 1.5 parts by weight of L-histidine hydrochloride-monohydrate, 2.0 to 4.0 parts by weight of L-lysine hydrochloride, 0.4 to 0.8 parts by weight of L-methionine, 0.4 to 0.8 parts by weight of L-proline, 1.5 to 2.5 parts by weight of L-threonine, and 1.5 to 2.5 parts by weight of L-valine. By including amino acid components in the content within the above range, it is possible to help cell growth and maintenance and improve formulation stability.
[0040] In the above cell culture medium, the vitamin component plays a role in maintaining cell activity, and may include 0.2 to 0.9 parts by weight of i-inositol, 0.04 to 0.8 parts by weight of thiamine hydrochloride, 0.04 to 0.8 parts by weight of niacinamide, and 0.04 to 0.8 parts by weight of pyridoxine hydrochloride based on 1 part by weight of amino acid serine.
[0041] In one embodiment, the vitamin component and content included in the cell culture medium may be 0.4 to 0.7 parts by weight of i-inositol, 0.06 to 0.2 parts by weight of thiamine hydrochloride, 0.06 to 0.2 parts by weight of niacinamide, and 0.06 to 0.2 parts by weight of pyridoxine hydrochloride based on 1 part by weight of amino acid serine. By including the vitamin component in an amount within the above range, it may help maintain cell activity.
[0042] The above-mentioned inorganic salt component plays a role in regulating the expression of cell function, and may include 50 to 200 parts by weight of sodium chloride (NaCl), 50 to 120 parts by weight of sodium bicarbonate (NaHCO3), 2.0 to 20 parts by weight of potassium chloride (KCl), 1.0 to 10 parts by weight of calcium chloride (CaCl2) (anhydrous), and 0.5 to 5.0 parts by weight of sodium biphosphate monohydrate (NaH2PO4-H2O) based on 1 part by weight of amino acid serine.
[0043] In one embodiment, the inorganic salt component and content included in the cell culture medium may be 100 to 150 parts by weight of sodium chloride (NaCl), 80 to 100 parts by weight of sodium bicarbonate (NaHCO3), 8 to 15 parts by weight of potassium chloride (KCl), 2.0 to 8.0 parts by weight of calcium chloride (CaCl2) (anhydrous), and 1.0 to 4.0 parts by weight of sodium biphosphate monohydrate (NaH2PO4-H2O) based on 1 part by weight of amino acid serine.
[0044] The above other components may include components that can improve the stability of the cell culture medium, etc., and may include 0.5 to 5.0 parts by weight of sodium pyruvate based on 1 part by weight of amino acid serine.
[0045] In one embodiment, the other components and contents included in the cell culture medium may be 1.0 to 4.0 parts by weight of sodium pyruvate based on 1 part by weight of amino acid serine. Other components included in the contents within the above range may help improve formulation stability, etc.
[0046] The albumin included in the above composition may be human serum albumin or bovine serum albumin.
[0047] The above human serum albumin is serum albumin found in human blood and is the most abundant protein present in human plasma. In the present invention, the human serum albumin may specifically be recombinant human serum albumin. Furthermore, the above bovine serum albumin is serum albumin found in cattle and is often used as a protein concentration standard in experiments.
[0048] The above albumin content may be contained in a concentration of 10 μg / ml, 50 μg / ml, 100 μg / ml, 200 μg / ml, 300 μg / ml, 500 μg / ml, or 1000 μg / ml. Alternatively, the above albumin content may be contained in a concentration of 10 to 1000 μg / ml, 50 to 500 μg / ml, or 100 to 250 μg / ml.
[0049] The above cosmetic composition may be for improving skin condition.
[0050] The above skin condition improvement may include at least one selected from the group consisting of skin moisturizing, skin aging improvement, skin barrier strengthening, skin wrinkle improvement, skin elasticity enhancement, skin texture improvement, skin transparency enhancement, skin blemish and freckle removal, skin whitening, and skin regeneration.
[0051] The term "skin moisturizing" in this specification may mean any action that maintains skin moisture or prevents moisture loss.
[0052] The term "skin aging" in this specification refers to a general term for tangible and intangible changes that occur in the skin with age, such as thinning of the epidermis, decreases in the number of cells or blood vessels in the dermis, DNA damage repair ability, cell turnover cycle, wound healing, skin barrier function, moisture retention in the epidermis, sweat secretion, sebum secretion, vitamin D production, physical damage defense, chemical removal ability, immune response, sensory function, and temperature regulation.
[0053] The above-mentioned improvement in skin aging may refer to improvement in skin aging caused by exogenous or endogenous factors. The exogenous factors refer to various external factors, such as ultraviolet rays (light), and the endogenous factors, also referred to as chronological factors, mainly refer to factors that occur over time. In other words, the above-mentioned skin aging is a concept that includes not only premature aging symptoms induced by external stimuli such as ultraviolet rays, pollution, cigarette smoke, and chemicals, but also natural aging phenomena that occur due to a decrease in skin cell proliferation with age, such as wrinkles, loss of elasticity, sagging skin, and dryness. In addition, wrinkles include those caused by changes in internal and external factors that change the components that make up the skin tissue, thereby inducing wrinkles.
[0054] The aforementioned aging may be photoaging. The term "photoaging" refers to a phenomenon caused by external environmental factors, the most common of which is ultraviolet rays. Ultraviolet rays cause damage to biological components, including the activation of proteolytic enzymes, chain scission of substrate proteins, and abnormal cross-linking. The repetition of these mechanisms leads to visible skin aging.
[0055] The term "skin barrier strengthening" in this specification may mean any action that enhances the function of the skin barrier, which is located at the outermost part of the skin and prevents moisture and nutrient loss.
[0056] As used herein, the term "wrinkle" refers to a condition in which skin loses elasticity and becomes loose, such as folds. The term "wrinkle prevention or improvement" may refer to any action that prevents or improves wrinkles by suppressing the expression of factors associated with wrinkles, or increases the total amount of collagen.
[0057] As used herein, the term "skin transparency" refers to the ratio of transmitted light to incident light at the skin surface. Incident light is scattered at the skin surface, some of which is then transmitted into the skin, and the remainder is reflected back out from within the skin. The transmitted light (transmitted light) then reflects back out from within the skin. As the amount of light reflected from within the skin (diffuse reflection) increases, skin transparency increases.
[0058] The term "improving skin elasticity" as used herein means alleviating the degree to which the skin sags or stretches.
[0059] The term "skin microrelief" in this specification refers to the three-dimensional microstructure formed by fine lines on the skin surface. It serves as an indicator of skin condition, separate from elasticity, wrinkles, and moisture retention. More specifically, skin texture is a reliable indicator of aging, allowing for the detection of aging before it begins. Furthermore, skin texture is not simply a rough or smooth surface condition, but rather reflects the underlying skin condition. The visible surface texture is merely a portion of the overall skin structure, and damage to skin texture reflects changes within the skin.
[0060] The term "skin regeneration" in this specification may refer to any action that replenishes a portion of skin that has been lost or promotes the proliferation of skin cells. Specifically, skin regeneration may refer to the regeneration of skin tissue at the site of a skin wound.
[0061] The term "skin whitening" as used herein may mean not only brightening the skin tone by inhibiting the synthesis of melanin pigment, but also improving skin hyperpigmentation such as freckles or blemishes caused by ultraviolet rays, hormones, or genetics.
[0062] The term "blemish" in this specification is believed to be caused by a complex interaction of various factors, such as cloudiness or shade due to thickening of the stratum corneum accompanying aging, decreased redness of the skin, pigmentation, decreased skin elasticity, yellowing of the skin, and contamination by sweat or sebum.
[0063] The above cosmetic composition may have enhanced skin condition improvement efficiency, and specifically, may have enhanced skin condition improvement efficiency compared to a composition that does not include a cell culture medium and / or albumin as an active ingredient.
[0064] The above cell culture medium and albumin, or a cosmetic composition containing the same, may be for anti-inflammatory purposes.
[0065] The term "anti-inflammation" in this specification means the process of causing inflammation or the property or efficacy of suppressing it, and the anti-inflammation may refer to one or more selected from the group consisting of 1) improving or alleviating skin inflammation, 2) soothing the skin, and 3) improving or preventing dermatitis.
[0066] The above skin soothing means calming or alleviating irritation, heat and / or pain of irritated skin.
[0067] The above dermatitis may include one or more selected from the group consisting of atopic dermatitis, allergic dermatitis, eczema, contact dermatitis, erythema, and psoriasis.
[0068] The above cell culture medium and albumin, or a cosmetic composition containing the same, may suppress the production, activity, or expression of inflammatory cytokines.
[0069] The above inflammatory cytokine may include one or more selected from the group consisting of TNF-α, IL-1β, IL-4, IL-6, IL-8, IL-9, and IL-13.
[0070] The above cosmetic composition may be for improving skin condition by alleviating inflammation.
[0071] The above cosmetic composition may have improved skin condition improvement efficiency by alleviating inflammation, and specifically, may have improved skin condition improvement efficiency compared to a composition that does not include a cell culture medium and / or albumin as an active ingredient.
[0072] Specifically, the skin condition improvement efficiency of the cosmetic composition may be increased by 10% or more, 30% or more, 50% or more, 70% or more, 100% or more, 150% or more, 200% or more, or 300% or more, compared to a composition that does not contain a cell culture medium and / or albumin as an active ingredient, and specifically, 10% to 300%, 10% to 200%, 10% to 150%, 10% to 100%, 10% to 70%, 10% to 50%, 30% to 300%, 30% to 200%, 30% to 150%, 30% to 100%, 30% to 70%, 30% to 50%, 50% to 300%, 50% to 200%, It may be enhanced by 50% to 150%, 50% to 100%, or 50% to 70%.
[0073] The formulation of the above cosmetic composition is not particularly limited, and may have any one formulation selected from among skin products, lotions, essences, creams, packs, foundations, patches, hair tonics, micro needle patches, and makeup bases, but may not be limited thereto.
[0074] The above cosmetic composition may contain optionally selected substances according to the formulation or intended use of the cosmetic, but may not be limited thereto. For example, purified water, oil, surfactants, moisturizers, higher alcohols, thickeners, chelating agents, pigments, fatty acids, antioxidants, preservatives, waxes, pH regulators, fragrances, etc. may be added, but may not be limited thereto.
[0075] When the formulation of the above cosmetic composition is a paste, cream or gel, it may include, but is not limited to, animal oil, vegetable oil, wax, paraffin, starch, tragacanth, cellulose derivatives, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide as a carrier component.
[0076] When the formulation of the above cosmetic composition is a powder or spray, it may include lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder as a carrier component, and in particular, when it is a spray, it may additionally include a propellant such as chlorofluorohydrocarbon, propane / butane or dimethyl ether, but may not be limited thereto.
[0077] When the formulation of the above cosmetic composition is a solution or emulsion, it may include a solvent, a solubilizer or an emulsifier as a carrier component, and may include, but is not limited to, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
[0078] When the formulation of the above cosmetic composition is a suspension, it may include, but is not limited to, a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tragacanth as a carrier component.
[0079] When the formulation of the above cosmetic composition is a surfactant-containing cleansing, the carrier component may include, but is not limited to, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester.
[0080] As an example of the above cosmetic composition formulation, skin care products including emollient toner, astringent toner, nourishing toner, lotion, gel, cream, essence, eye essence, eye cream, nourishing cream, massage cream, clay pack, and mask pack, makeup products including lipstick, lip tint, lip gloss, lip pencil, eye shadow, foundation, powder, concealer, eyeliner, eye shadow, and mascara, eye remover, makeup remover, cleansing foam, cleansing cream, cleansing oil, cleansing water, hand sanitizer, hand wash, hand scrub, body wash, body scrub, shaving lotion, soap, and wet tissue, cleaning products including body lotion, body oil, body mist, body essence, hand cream, foot cream, and wax-type hair removal agent, infant cosmetics including baby lotion, baby cream, and diaper rash cream, sunscreen, and sun stick, Sun care products including sun sprays and artificial tanning products, hair products including shampoos, rinses, hair conditioner creams, hair styling gels, foams, hair mousses, hair sprays, styling lotions, styling creams, hair essences, hair dyes, hair bleaching creams, and curl activator gels, nail care products including nail polishes, nail polishes, cuticle removers, and cuticle creams, toothpastes, mouthwashes, mouth rinses, mouth films, and personal care products including gums, perfumes, plant extracts, deodorants, and antiperspirant formulations.
[0081] The above cosmetic composition may additionally contain a dissolution enhancer.
[0082] The above-mentioned dissolution enhancer may improve the solubility of cell culture medium components and albumin in the composition, and specifically may improve the solubility in an aqueous solution such as purified water.
[0083] The above dissolution enhancer may include a pH adjuster.
[0084] The pH regulator may be one that reduces the pH of the added composition, and specifically, the pH regulator may be an acidic substance.
[0085] The above pH regulator may be added in an amount appropriate for controlling the pH to be obtained in the composition, and specifically may be added to control the pH of the entire composition within a range of 3.0 to 9.0.
[0086] In one embodiment, the composition may have a pH of 3.0 to 9.0, specifically a pH of 6.0 to 8.0, and more specifically a pH of 3.0 to 9.0, 3.0 to 8.5, 3.0 to 8.0, 3.0 to 7.8, 3.0 to 7.6, 3.0 to 7.5, 3.5 to 9.0, 3.5 to 8.5, 3.5 to 8.0, 3.5 to 7.8, 3.5 to 7.6, 3.5 to 7.5, 4.0 to 9.0, 4.0 to 8.5, 4.0 to 8.0, 4.0 to 7.8, 4.0 to 7.6, 4.0 to 7.5, 4.5 to 9.0, 4.5 to 8.5, 4.5 to 8.0, 4.5 to 7.8, 4.5 to 7.6, 4.5 to 7.5, 5.0 to 9.0, 5.0 to 8.5, 5.0 to 8.0, 5.0 to 7.8, 5.0 to 7.6, 5.0 to 7.5, 5.5 to 9.0, 5.5 to 8.5, 5.5 to 8.0, 5.5 to 7.8, 5.5 to 7.6, 5.5 to 7.5, 6.0 to 9.0, 6.0 to 8.5, 6.0 to 8.0, 6.0 to 7.8, 6.0 to 7.6, 6.0 to 7.5, 6.5 to 9.0, 6.5 to 8.5, 6.5 to 8.0, 6.5 to 7.8, 6.5 to 7.6, 6.5 to 7.5, 7.0 to 9.0, 7.0 to 8.5, 7.0 to 8.0, 7.0 to 7.8, 7.0 to 7.6, 7.0 to 7.5, 7.2 to 9.0, 7.2 to 8.5, 7.2 to 8.0, 7.2 to 7.8, 7.2 to 7.6, 7.2 to 7.5, 7.4 to 9.0, 7.4 to 8.5, 7.4 to 8.0, 7.4 to 7.8, 7.4 to 7.6, 7.4 to 7.5, 7.5 to 9.0, 7.5 to 8.5, 7.5 to It may have a pH in the range of 8.0, 7.5 to 7.8 or 7.5 to 7.6.
[0087] The above pH adjusting agent may include an organic acid and / or an inorganic acid.
[0088] The organic acid may include alpha hydroxy acid (AHA) and / or beta hydroxy acid (BHA).
[0089] The term "alpha hydroxy acid (AHA)" in this specification refers to a compound in which an alcohol group or a hydroxy group is added to a carbon atom at the α position of a carboxylic acid. In addition, the term "beta hydroxy acid (BHA)" refers to a compound in which an alcohol group or a hydroxy group is added to a carbon atom at the β position of a carboxylic acid.
[0090] The pH adjusting agent is citric acid, salicylic acid, glycolic acid, lactic acid, malic acid, tartaric acid, mandelic acid, polyhydroxy acid (PHA), b-lipohydroxy acid (LHA), oxalic acid, gluconolactone, ascorbic acid, glutamic acid, D-gluconic acid, sulfonic acid, methanesulfonic acid, benzimidazole sulfonic acid, 4-aminobenzoic acid, benzoic acid, sorbic acid, phenylbenzimidazole sulfonic acid, benzylidene camphor. It may include at least one selected from the group consisting of benzylidene camphor sulfonic acid, terephthalylidene dicamphor sulfonic acid, kojic acid, hyaluronic acid, phosphoric acid, carbonic acid, hydrochloric acid, acetic acid, and formic acid, and may specifically include citric acid. The composition may be a cosmetic composition, and specifically, may be a cosmetic composition for improving skin condition.
[0091] The above cosmetic composition may be an oil-in-water (O / W) type.
[0092] The above cell culture medium and albumin may be 0.0001 to 10 wt% based on the total weight of the composition, and specifically, 0.0001 to 10 wt%, 0.0001 to 5 wt%, 0.0001 to 3 wt%, 0.0001 to 2 wt%, 0.0001 to 1 wt%, 0.001 to 10 wt%, 0.001 to 5 wt%, 0.001 to 3 wt%, 0.001 to 2 wt%, 0.001 to 1 wt%, 0.01 to 10 wt%, 0.01 to 5 wt%, 0.01 to 3 wt%, 0.01 to 2 wt%, 0.01 to 1 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to It may be included in an amount of 3 wt%, 0.1 to 2 wt%, 0.1 to 1 wt%, 0.25 to 10 wt%, 0.25 to 5 wt%, 0.25 to 3 wt%, 0.25 to 2 wt%, 0.25 to 1 wt%, 0.5 to 10 wt%, 0.5 to 5 wt%, 0.5 to 3 wt%, 0.5 to 2 wt%, 0.5 to 1 wt%, 0.75 to 10 wt%, 0.75 to 5 wt%, 0.75 to 3 wt%, 0.75 to 2 wt%, or 0.75 to 1 wt%.
[0093] The above-mentioned water-in-water composition may additionally include at least one selected from the group consisting of a surfactant, wax, butter, thickener (stabilizer), higher alcohol, and higher fatty acid.
[0094] The above surfactant may include, but is not limited to, one or more selected from the group consisting of glyceryl stearate SE, cetearyl alcohol, cetearyl glucoside, glyceryl stearate, PEG-100 stearate, glyceryl stearate / PEG-100 stearate, C14-22 alcohol, C12-20 alkyl glucoside, C14-22 alcohol / C12-20 alkyl glucoside, polyglyceryl-3 methyl glucose distearate, polyglyceryl-6 stearate, polyglyceryl-6 behenate, polyglyceryl-6 stearate / polyglyceryl-6 behenate, C12-16 alcohol, palmitic acid, hydrogenated lecithin, and 2-16 alcohol / palmitic acid / hydrogenated lecithin.
[0095] The surfactant may be 0.01 to 10 wt% based on the total weight of the composition, specifically 0.01 to 10 wt%, specifically 0.01 to 10 wt%, 0.01 to 5 wt%, 0.01 to 4 wt%, 0.01 to 3 wt%, 0.01 to 2 wt%, 0.01 to 1.5 wt%, 0.01 to 1 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to 4 wt%, 0.1 to 3 wt%, 0.1 to 2 wt%, 0.1 to 1.5 wt%, 0.1 to 1 wt%, 0.5 to 10 wt%, 0.5 to 5 wt%, 0.5 to 4 wt%, 0.5 to 3 wt%, 0.5 to 2 It may be included in an amount of 0.5 to 1.5 wt%, 0.5 to 1 wt%, 1 to 10 wt%, 1 to 5 wt%, 1 to 4 wt%, 1 to 3 wt%, 1 to 2 wt%, 1 to 1.5 wt%, 1.5 to 10 wt%, 1.5 to 5 wt%, 1.5 to 4 wt%, 1.5 to 3 wt%, 1.5 to 2 wt%, 2 to 10 wt%, 2 to 5 wt%, 2 to 4 wt%, 2 to 3 wt%, 2.5 to 10 wt%, 2.5 to 5 wt%, 2.5 to 4 wt%, 2.5 to 3 wt%, 3 to 10 wt%, 3 to 5 wt%, or 3 to 4 wt%.
[0096] The above surfactant may not include at least one selected from the group consisting of polysorbate 60 and sorbitan sesquioleate.
[0097] The thickener may include at least one selected from the group consisting of guar gum, carrageenan, xanthan gum, carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, polyacrylate-13, polyacrylate crosspolymer-6, polyacrylamide, sodium acrylate / sodium acryloyldimethyltaurate copolymer, and hydroxyethyl acrylate / sodium acryloyldimethyltaurate copolymer for the purpose of controlling the viscosity of the continuous phase.
[0098] The thickener may be 0.01 to 10 wt% based on the total weight of the composition, and specifically, 0.01 to 10 wt%, 0.01 to 5 wt%, 0.01 to 4 wt%, 0.01 to 3 wt%, 0.01 to 2 wt%, 0.01 to 1.5 wt%, 0.01 to 1 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to 4 wt%, 0.1 to 3 wt%, 0.1 to 2 wt%, 0.1 to 1.5 wt%, 0.1 to 1 wt%, 0.5 to 10 wt%, 0.5 to 5 wt%, 0.5 to 4 wt%, 0.5 to 3 wt%, 0.5 to 2 wt%, 0.5 to 1.5 wt%, It may be included in an amount of 0.5 to 1 wt%, 0.7 to 10 wt%, 0.7 to 5 wt%, 0.7 to 4 wt%, 0.7 to 3 wt%, 0.7 to 2 wt%, 0.7 to 1.5 wt%, 0.7 to 1 wt%, 0.9 to 10 wt%, 0.9 to 5 wt%, 0.9 to 4 wt%, 0.9 to 3 wt%, 0.9 to 2 wt%, 0.9 to 1.5 wt%, or 0.9 to 1 wt%.
[0099] In one embodiment, the cosmetic composition may not contain carbomer as a thickening agent.
[0100] The above wax may include at least one selected from the group consisting of beeswax, candelilla wax, carnauba wax, multiwax, paraffin wax, microcrystal wax, and ceresin wax.
[0101] The above butter may include at least one selected from the group consisting of shea butter, mango seed butter, cocoa seed butter, cupuacu seed butter, palm seed butter, triciriaimetica seed butter, kokum seed butter, borneo tallow seed butter, and sal tree seed butter.
[0102] The above-mentioned higher alcohol may include at least one selected from the group consisting of cetyl alcohol, stearyl alcohol, cetearyl alcohol, behenyl alcohol, and batyl alcohol.
[0103] The above-mentioned higher fatty acid may include at least one selected from the group consisting of stearic acid, isostearic acid, myristic acid, and palmitic acid.
[0104] In addition to the ingredients described above, the above cosmetic composition may further include purified water (solvent), a moisturizer, a pH adjuster, a neutralizer, a metal ion sequestering agent, and / or a preservative.
[0105] The above preservative may include, but is not limited to, one or more selected from the group consisting of phenoxyethanol and hexanediol.
[0106] The above moisturizer may include, but is not limited to, glycerin.
[0107] The above cosmetic composition may further include oil and / or silicone-based elastomer in addition to the above-described ingredients.
[0108] The above oil may be any oil commonly used in cosmetics, without limitation on its type. For example, the above oil may be at least one selected from the group consisting of ester oils, hydrocarbon oils, silicone oils, vegetable oils, and triglycerides.
[0109] The ester oil may be an ester compound of a fatty acid and a fatty alcohol. For example, the ester oil may include isopropyl myristate, isopropyl palmitate, ethylhexyl palmitate, cetyl octanoate, cetyl 2-ethyl hexanoate, 2-octyl dodecyl myristate, di-isostearyl malate, and the like.
[0110] The above hydrocarbon oil may include petroleum oils such as liquid paraffin, petrolatum, and isoparaffins; synthetic oils such as hydrogenated polydecene, synthetic squalane, and polybutene; and plant oils such as vegetable squalane and hydrogenated squalane.
[0111] The silicone-based oil may be an oil having a siloxane bond (Si-O-Si). For example, the silicone-based oil may include dimethicone, dimethiconol, phenyl trimethicone, disiloxane, cyclomethicone, cyclopentasiloxane, cyclohexasiloxane, etc.
[0112] The above vegetable oil may be obtained from plants that exist in nature. For example, the vegetable oil may include olive oil, meadowfoam seed oil, rosehip fruit oil, avocado oil, camellia oil, apple seed oil, grape seed oil, sunflower seed oil, macadamia nut oil, coconut oil, castor oil, jojoba seed oil, caprylic / capric triglyceride, etc.
[0113] In one embodiment, the cosmetic composition may be an oil-in-water cosmetic composition comprising 1) an aqueous phase comprising a cell culture medium, albumin and / or a thickening agent; and 2) an oil phase comprising a surfactant.
[0114] The aqueous portion of the above cosmetic composition may additionally include at least one selected from the group consisting of purified water, a moisturizer, and a preservative.
[0115] The oil phase of the above cosmetic composition may additionally include one or more selected from the group consisting of oil, higher alcohol, higher fatty acid, butter, and wax.
[0116] In one embodiment, the cosmetic composition may be a W / O (oil-in-water) emulsion formulation. The cosmetic composition of the present invention may be formulated as, for example, a liquid product, lotion, essence, cream, sun lotion, sunscreen, makeup base, foundation, BB cream, stick product, or balm-type product, but is not limited thereto. In addition, depending on the formulation to be manufactured, oil, water, surfactant, moisturizer, lower alcohol, thickener, chelating agent, preservative, fragrance, etc. may be additionally selected and mixed and added. In addition, a sunscreen, a light scattering agent, etc. may be included, and the formulation and added ingredients are not limited to the above. In addition, the above ingredients may be introduced in an amount generally used in the field of dermatology.
[0117] The above cosmetic composition may include additional ingredients commonly used in cosmetics, such as conventional adjuvants such as stabilizers, solvators, thickeners, dispersants, fragrances, fillers, preservatives, neutralizers, sweeteners, vitamins, antioxidants, and metal ion sequestering agents. Those skilled in the art can select any additional ingredients and / or their amounts so that the beneficial properties of the composition according to the present disclosure are not adversely affected or substantially not affected by the anticipated addition.
[0118] The above cosmetic composition may be a water-in-oil (W / O) type.
[0119] The above cell culture medium and albumin may be 0.0001 to 10 wt% based on the total weight of the composition, and specifically, 0.0001 to 10 wt%, 0.0001 to 5 wt%, 0.0001 to 3 wt%, 0.0001 to 2 wt%, 0.0001 to 1 wt%, 0.001 to 10 wt%, 0.001 to 5 wt%, 0.001 to 3 wt%, 0.001 to 2 wt%, 0.001 to 1 wt%, 0.01 to 10 wt%, 0.01 to 5 wt%, 0.01 to 3 wt%, 0.01 to 2 wt%, 0.01 to 1 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to It may be included in an amount of 3 wt%, 0.1 to 2 wt%, 0.1 to 1 wt%, 0.25 to 10 wt%, 0.25 to 5 wt%, 0.25 to 3 wt%, 0.25 to 2 wt%, 0.25 to 1 wt%, 0.5 to 10 wt%, 0.5 to 5 wt%, 0.5 to 3 wt%, 0.5 to 2 wt%, 0.5 to 1 wt%, 0.75 to 10 wt%, 0.75 to 5 wt%, 0.75 to 3 wt%, 0.75 to 2 wt%, or 0.75 to 1 wt%.
[0120] The above water-in-oil composition may further include one or more selected from the group consisting of a surfactant, wax, butter, thickener (stabilizer), higher alcohol, and higher fatty acid.
[0121] In one embodiment, the water-in-oil composition may include a cell culture medium, albumin, a surfactant, wax, and a thickening agent (stabilizer).
[0122] The above surfactants are PEG-8 dimethicone, PEG-9 polydimethylsiloxyethyl dimethicone, PEG-10 dimethicone, PEG-12 dimethicone, PEG-11 methyl ether dimethicone, cetyl PEG / PPG dimethicone, cetyl PEG / PPG-10 / 1 dimethicone, bis-PEG / PPG-14 / 14 dimethicone, bis-PEG / PPG-20 / 20 dimethicone, PEG / PPG-18 / 18 dimethicone, PEG / PPG-19 / 19 dimethicone, PEG / PPG-20 / 20 dimethicone, polyglyceryl-3 polydimethylsiloxyethyl dimethicone, lauryl polyglyceryl-3 polydimethylsiloxyethyl dimethicone, and lauryl PEG-9 It may include one or more selected from the group consisting of polydimethylsiloxyethyl dimethicone, but is not limited thereto.
[0123] The surfactant may be present in an amount of 0.01 to 10 wt% based on the total weight of the composition, specifically, 0.01 to 10 wt%, 0.01 to 5 wt%, 0.01 to 4 wt%, 0.01 to 3 wt%, 0.01 to 2 wt%, 0.01 to 1 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to 4 wt%, 0.1 to 3 wt%, 0.1 to 2 wt%, 0.1 to 1 wt%, 0.5 to 10 wt%, 0.5 to 5 wt%, 0.5 to 4 wt%, 0.5 to 3 wt%, 0.5 to 2 wt%, 0.5 to 1 wt%, 1 to 10 wt%, 1 to 5 wt%, 1 to 4 wt%, 1 to It may be comprised in an amount of 3 wt%, 1 to 2 wt%, 2 to 10 wt%, 2 to 5 wt%, 2 to 4 wt%, 2 to 3 wt%, 3 to 10 wt%, 3 to 5 wt% or 3 to 4 wt%.
[0124] The wax may include, but is not limited to, one or more selected from the group consisting of beeswax, candelilla wax, carnauba wax, multiwax, paraffin wax, microcrystal wax, and ceresin wax.
[0125] The wax may be present in an amount of 0.01 to 10 wt% based on the total weight of the composition, specifically, 0.01 to 10 wt%, 0.01 to 5 wt%, 0.01 to 4 wt%, 0.01 to 3 wt%, 0.01 to 2 wt%, 0.01 to 1.5 wt%, 0.01 to 1 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to 4 wt%, 0.1 to 3 wt%, 0.1 to 2 wt%, 0.1 to 1.5 wt%, 0.1 to 1 wt%, 0.5 to 10 wt%, 0.5 to 5 wt%, 0.5 to 4 wt%, 0.5 to 3 wt%, 0.5 to 2 wt%, 0.5 to 1.5 wt%, 0.5 It may be included in an amount of 1 wt%, 1 to 10 wt%, 1 to 5 wt%, 1 to 4 wt%, 1 to 3 wt%, 1 to 2 wt%, or 1 to 1.5 wt%.
[0126] The above thickener may include at least one selected from the group consisting of hectorite, quaternium-18 hectorite, stearalkonium hectorite, and disteardimonium hectorite, but is not limited thereto, for the purpose of controlling the viscosity of the continuous phase and as a stabilizer.
[0127] The thickener (stabilizer) may be present in an amount of 0.01 to 10 wt% based on the total weight of the composition, specifically, 0.01 to 10 wt%, 0.01 to 5 wt%, 0.01 to 4 wt%, 0.01 to 3 wt%, 0.01 to 2 wt%, 0.01 to 1.5 wt%, 0.01 to 1 wt%, 0.1 to 10 wt%, 0.1 to 5 wt%, 0.1 to 4 wt%, 0.1 to 3 wt%, 0.1 to 2 wt%, 0.1 to 1.5 wt%, 0.1 to 1 wt%, 0.5 to 10 wt%, 0.5 to 5 wt%, 0.5 to 4 wt%, 0.5 to 3 wt%, 0.5 to 2 wt%, 0.5 to It may be included in an amount of 1.5 wt%, 0.5 to 1 wt%, 1 to 10 wt%, 1 to 5 wt%, 1 to 4 wt%, 1 to 3 wt%, 1 to 2 wt%, or 1 to 1.5 wt%.
[0128] The above butter may include at least one selected from the group consisting of shea butter, mango seed butter, cocoa seed butter, cupuacu seed butter, palm seed butter, triciriaimetica seed butter, kokum seed butter, borneo tallow seed butter and sala seed butter, but is not limited thereto.
[0129] The above higher alcohol may include, but is not limited to, one or more selected from the group consisting of cetyl alcohol, stearyl alcohol, behenyl alcohol, and batyl alcohol.
[0130] The above-mentioned higher fatty acids may include, but are not limited to, one or more selected from the group consisting of stearic acid, isostearic acid, myristic acid, and palmitic acid.
[0131] The above cosmetic composition may further include oil and / or silicone-based elastomer in addition to the above-described ingredients.
[0132] The above oil may be any oil commonly used in cosmetics, without limitation on its type. For example, the above oil may be at least one selected from the group consisting of ester oils, hydrocarbon oils, silicone oils, vegetable oils, and triglycerides.
[0133] The ester oil may be an ester compound of a fatty acid and a fatty alcohol. For example, the ester oil may include isopropyl myristate, isopropyl palmitate, ethylhexyl palmitate, cetyl octanoate, cetyl 2-ethyl hexanoate, 2-octyl dodecyl myristate, di-isostearyl malate, and the like.
[0134] The above hydrocarbon oil may include petroleum oils such as liquid paraffin, petrolatum, and isoparaffins; synthetic oils such as hydrogenated polydecene, synthetic squalane, and polybutene; and plant oils such as vegetable squalane and hydrogenated squalane.
[0135] The silicone-based oil may be an oil having a siloxane bond (Si-O-Si). For example, the silicone-based oil may include dimethicone, dimethiconol, phenyl trimethicone, disiloxane, cyclomethicone, cyclopentasiloxane, cyclohexasiloxane, etc.
[0136] The above vegetable oil may be obtained from plants that exist in nature. For example, the vegetable oil may include olive oil, meadowfoam seed oil, rosehip fruit oil, avocado oil, camellia oil, apple seed oil, grape seed oil, sunflower seed oil, macadamia nut oil, coconut oil, castor oil, jojoba seed oil, caprylic / capric triglyceride, etc.
[0137] The above silicone-based elastomer may refer to a material in which a silicone cross-linked product is swelled in silicone oil and various oils. The silicone-based elastomer may include a silicone-based crosspolymer. The silicone-based crosspolymer may include, but is not limited to, dimethicone crosspolymer, vinyl dimethicone crosspolymer, and the like. The silicone-based elastomer may include a dimethicone / vinyl dimethicone crosspolymer.
[0138] The above cosmetic composition may further include purified water, a moisturizer, a pH regulator, a metal ion sequestering agent, and / or a preservative in addition to the ingredients described above.
[0139] The above preservative may include, but is not limited to, one or more selected from the group consisting of propanediol, ethylhexylglycerin, 1,2-hexanediol, and pentylene glycol.
[0140] The above moisturizer may include, but is not limited to, glycerin.
[0141] The above metal ion sequestering agent may include, but is not limited to, disodium EDTA.
[0142] In one embodiment, the cosmetic composition may be a water-in-oil cosmetic composition comprising: 1) an aqueous phase comprising a cell culture medium and albumin; and 2) an oil phase comprising at least one selected from the group consisting of a thickener (stabilizer), a surfactant, and a wax.
[0143] The aqueous portion of the above cosmetic composition may additionally include at least one selected from the group consisting of purified water, a metal ion sequestering agent, a moisturizer, and a preservative.
[0144] The oil phase of the above cosmetic composition may additionally include at least one selected from the group consisting of oil and silicone-based elastomer.
[0145] In one embodiment, the cosmetic composition may be an O / W (water-in-oil) emulsion formulation. The cosmetic composition of the present invention may be formulated as, for example, a liquid product, a lotion, an essence, a cream, a sun lotion, a sunscreen, a makeup base, a foundation, a BB cream, a stick product, or a balm-type product, but is not limited thereto. In addition, depending on the formulation to be manufactured, oil, water, a surfactant, a moisturizer, a lower alcohol, a thickener, a chelating agent, a preservative, a fragrance, etc. may be additionally selected and mixed and added. In addition, a sunscreen, a light scattering agent, etc. may be included, and the formulation and added ingredients are not limited to the above. In addition, the above ingredients may be introduced in an amount generally used in the field of dermatology.
[0146] The above cosmetic composition may include additional ingredients commonly used in cosmetics, such as conventional adjuvants such as stabilizers, solvators, thickeners, dispersants, fragrances, fillers, preservatives, neutralizers, sweeteners, vitamins, antioxidants, and metal ion sequestering agents. Those skilled in the art can select any additional ingredients and / or their amounts so that the beneficial properties of the composition according to the present disclosure are not adversely affected or substantially not affected by the anticipated addition.
[0147] Another aspect provides a composition for topical skin application comprising a cell culture medium and albumin as active ingredients. The same aspects described above also apply to the composition.
[0148] The above skin external application composition may be for improving skin condition.
[0149] The above skin condition improvement may include at least one selected from the group consisting of skin moisturizing, skin aging improvement, skin barrier strengthening, skin wrinkle improvement, skin elasticity enhancement, skin texture improvement, skin transparency enhancement, skin blemish removal, skin whitening, and skin regeneration.
[0150] The above-mentioned external skin composition may be a cream, gel, ointment, skin emulsifier, skin suspension, transdermal delivery patch, drug-containing bandage, lotion, or a combination thereof. The external skin composition according to each formulation can be appropriately selected and blended by a person skilled in the art according to the formulation or intended use of other external skin compositions, in addition to the composition of the present invention, without difficulty. In this case, a synergistic effect may occur when applied simultaneously with other raw materials.
[0151] The above skin external preparation may be appropriately mixed with ingredients commonly used in skin external preparations such as cosmetics or medicines, such as aqueous ingredients, oily ingredients, powder ingredients, alcohols, moisturizers, thickeners, ultraviolet absorbers, whitening agents, preservatives, antioxidants, surfactants, fragrances, colorants, various skin nutrients, or combinations thereof, as needed.
[0152] The above skin external preparation may also appropriately contain metal sequestrants such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, and gluconic acid; caffeine, tannin, bellapamil, licorice extract, glabridin, hot water extract of the fruit of Kalin; various herbal medicines; tocopheryl acetate, glycyrrhizic acid, tranexamic acid and derivatives or salts thereof; and sugars such as vitamin C, magnesium ascorbic acid phosphate, ascorbic acid glucoside, arbutin, kojic acid, glucose, fructose, and trehalose.
[0153] The above skin external composition may be for anti-inflammatory purposes.
[0154] The above skin external preparation composition may be an oil-in-water type or a water-in-oil type.
[0155] Another aspect provides a method for improving the solubility of a composition comprising a cell culture medium and albumin, comprising the steps of: 1) dissolving components of a cell culture medium and albumin in a solvent; and 2) adding a solubility enhancer to the solution obtained in the above step and mixing the mixture. The same parts as described above also apply to the above method.
[0156] The method may include a step of adjusting the pH of the solution to a range of 3.0 to 9.0 by adding the dissolution enhancer, wherein the dissolution enhancer may be a pH adjuster.
[0157] In one embodiment, the composition may be adjusted to have a pH of 3.0 to 9.0, specifically, may be adjusted to have a pH of 6.0 to 8.0, and more specifically, 3.0 to 9.0, 3.0 to 8.5, 3.0 to 8.0, 3.0 to 7.8, 3.0 to 7.6, 3.0 to 7.5, 3.5 to 9.0, 3.5 to 8.5, 3.5 to 8.0, 3.5 to 7.8, 3.5 to 7.6, 3.5 to 7.5, 4.0 to 9.0, 4.0 to 8.5, 4.0 to 8.0, 4.0 to 7.8, 4.0 to 7.6, 4.0 to 7.5, 4.5 to 9.0, 4.5 to 8.5, 4.5 to 8.0, 4.5 to 7.8, 4.5 to 7.6, 4.5 to 7.5, 5.0 to 9.0, 5.0 to 8.5, 5.0 to 8.0, 5.0 to 7.8, 5.0 to 7.6, 5.0 to 7.5, 5.5 to 9.0, 5.5 to 8.5, 5.5 to 8.0, 5.5 to 7.8, 5.5 to 7.6, 5.5 to 7.5, 6.0 to 9.0, 6.0 to 8.5, 6.0 to 8.0, 6.0 to 7.8, 6.0 to 7.6, 6.0 to 7.5, 6.5 to 9.0, 6.5 to 8.5, 6.5 to 8.0, 6.5 to 7.8, 6.5 to 7.6, 6.5 to 7.5, 7.0 to 9.0, 7.0 to 8.5, 7.0 to 8.0, 7.0 to 7.8, 7.0 to 7.6, 7.0 to 7.5, 7.2 to 9.0, 7.2 to 8.5, 7.2 to 8.0, 7.2 to 7.8, 7.2 to 7.6, 7.2 to 7.5, 7.4 to 9.0, 7.4 to 8.5, 7.4 to 8.0, 7.4 to 7.8, 7.4 to 7.6, 7.4 to 7.5, 7.5 to 9.0, 7.5 to 8.5, It may be adjusted to have a pH in the range of 7.5 to 8.0, 7.5 to 7.8, or 7.5 to 7.6.
[0158] Another aspect is to provide a composite powder comprising a cell culture medium, albumin and a porous polymer.
[0159] In the above composite powder, the cell culture medium and albumin may be impregnated into the porous polymer, and specifically, may be evenly impregnated into the surface and interior of the spherical porous polymer.
[0160] The porous polymer may include at least one selected from the group consisting of polymethyl methacrylate [PMMA: poly-(methyl methacrylate)], polyvinyl pyrrolidone [PVP: poly-(vinyl pyrrolidone)], polycaprolactone [PCL: poly-(caprolactone)], polymethylsilsesquioxane [PMSQ: polymethylsilsesquioxane], silica, and poly-L-lactic acid [PLLA: poly-(L-Lactic Acid)], and specifically, may include polymethyl methacrylate. In addition, the porous polymer may be a porous polymer powder.
[0161] The above composite powder may have an enhanced level of homogenization, and specifically, may have an enhanced level of homogenization compared to a composition comprising a cell culture medium and albumin without including a porous polymer.
[0162] Specifically, the homogenization level of the composite powder may be enhanced by 10% or more, 30% or more, 50% or more, 70% or more, 100% or more, 150% or more, 200% or more, or 300% or more, compared to a composition comprising a cell culture medium and albumin and not including a porous polymer, and specifically, 10% to 300%, 10% to 200%, 10% to 150%, 10% to 100%, 10% to 70%, 10% to 50%, 30% to 300%, 30% to 200%, 30% to 150%, 30% to 100%, 30% to 70%, 30% to 50%, 50% to 300%, 50% to 200%, It may be enhanced by 50% to 150%, 50% to 100%, or 50% to 70%.
[0163] Another aspect provides a method for producing a composite powder comprising a cell culture medium and albumin, comprising the steps of: 1) dissolving or dispersing a cell culture medium, albumin, and a porous polymer in a solvent; and 2) spray-drying the solution or dispersion. The same parts as described above also apply to the method.
[0164] In the above method, 'step 1' is a step of preparing a solution in which a cell culture medium, albumin, and a porous polymer are dissolved, mixed, or dispersed, and may specifically include a step of dissolving a cell culture medium and albumin in a solvent and mixing or dispersing a porous polymer in the solution.
[0165] The solvent may be an organic solvent, and may include at least one selected from the group consisting of ethanol, methanol, acetone and dichloromethane, and specifically may include methanol and dichloromethane.
[0166] The solvent may contain methanol and dichloromethane in a volume ratio of 0.5:9.5 to 3:7, and specifically, may contain methanol and dichloromethane in a volume ratio of 0.5:9.5 to 3:7, 0.5:9.5 to 2.5:7.5, 0.5:9.5 to 2:8, 0.5:9.5 to 1.5:8.5, 1.0:9.0 to 3:7, 1.0:9.0 to 2.5:7.5, 1.0:9.0 to 2:8, 1.0:9.0 to 1.5:8.5, 1.5:8.5 to 3:7, 1.5:8.5 to 2.5:7.5, or 1.5:8.5 to 2:8.
[0167] In the above method, 'step 2' may include a step of producing a composite powder in which the cell culture medium and albumin are evenly impregnated into the porous polymer powder by spraying the mixture or dispersion of the 'step 1' by spray drying.
[0168] The term "spray drying" used herein refers to a drying method that obtains solid particles by exposing a mixture of solid and liquid to a hot air stream to instantaneously evaporate the liquid from the solution. Spray drying requires a process of generating a high-temperature hot air stream to evaporate the liquid, and a process of atomizing and spraying the liquid-solid mixture using a nozzle or sprayer.
[0169] The above spray drying step may be performed by one or more selected from the group consisting of a disk type spray dryer and a nozzle type spray dryer.
[0170] In the above spray drying step, the air inlet temperature of the spray dryer may be 80 to 120 ℃, specifically 80 to 120 ℃, 80 to 115 ℃, 80 to 110 ℃, 80 to 105 ℃, 80 to 100 ℃, 80 to 95 ℃, 85 to 120 ℃, 85 to 115 ℃, 85 to 110 ℃, 85 to 105 ℃, 85 to 100 ℃, 85 to 95 ℃, 90 to 120 ℃, 90 to 115 ℃, 90 to 110 ℃, 90 to 105 ℃, 90 to 100 ℃, 90 to 95 ℃, 95 to 120 ℃, 95 to It can be 115 ℃, 95 to 110 ℃, 95 to 105 ℃ or 95 to 100 ℃.
[0171] In the above spray drying step, the chamber temperature of the spray dryer may be 60 to 90°C, and specifically, 60 to 90°C, 60 to 85°C, 60 to 80°C, 60 to 75°C, 65 to 90°C, 65 to 85°C, 65 to 80°C, 65 to 75°C, 70 to 90°C, 70 to 85°C, 70 to 80°C, or 70 to 75°C.
[0172] In the above spray drying step, the disk rotation speed of the disk type spray dryer may be 6,000 to 10,000 rpm / min, specifically 6,000 to 10,000 rpm / min, 6,000 to 9,500 rpm / min, 6,000 to 9,000 rpm / min, 6,000 to 8,500 rpm / min, 6,000 to 8,000 rpm / min, 6,000 to 7,500 rpm / min, 6,500 to 10,000 rpm / min, 6,500 to 9,500 rpm / min, 6,500 to 9,000 rpm / min, 6,500 to 8,500 rpm / min, 6,500 to 8,000 rpm / min, It may be 6,500 to 7,500 rpm / min, 7,000 to 10,000 rpm / min, 7,000 to 9,500 rpm / min, 7,000 to 9,000 rpm / min, 7,000 to 8,500 rpm / min, 7,000 to 8,000 rpm / min, 7,000 to 7,500 rpm / min, 7,500 to 10,000 rpm / min, 7,500 to 9,500 rpm / min, 7,500 to 9,000 rpm / min, 7,500 to 8,500 rpm / min or 7,500 to 8,000 rpm / min.
[0173] In the above spray drying step, the flow rate may be 10 to 20 kg / h, and specifically, 10 to 20 kg / h, 10 to 19 kg / h, 10 to 18 kg / h, 10 to 17 kg / h, 12 to 20 kg / h, 12 to 19 kg / h, 12 to 18 kg / h, 12 to 17 kg / h, 14 to 20 kg / h, 14 to 19 kg / h, 14 to 18 kg / h, 14 to 17 kg / h, 16 to 20 kg / h, 16 to 19 kg / h, 16 to 18 kg / h or 16 to 17 kg / h.
[0174] The above method may be for improving the homogenization level of a composition comprising a cell culture medium and albumin, and specifically for homogenizing particles despite differences in crystal form, size and specific gravity of the components.
[0175] Another aspect provides a composition comprising a composite powder comprising a cell culture medium, albumin, and a porous polymer. The same aspects described above also apply to the composition.
[0176] The above composite powder may be manufactured using the above-described composite powder manufacturing method.
[0177] The above composition may be a cosmetic composition.
[0178] The formulation of the above cosmetic composition is not particularly limited, and may have any one formulation selected from among skin products, lotions, essences, creams, packs, foundations, patches, hair tonics, micro needle patches, and makeup bases, but may not be limited thereto.
[0179] The above cosmetic composition may contain optionally selected substances according to the formulation or intended use of the cosmetic, but may not be limited thereto. For example, purified water, oil, surfactants, moisturizers, higher alcohols, thickeners, chelating agents, pigments, fatty acids, antioxidants, preservatives, waxes, pH regulators, fragrances, etc. may be added, but may not be limited thereto.
[0180] When the formulation of the above cosmetic composition is a paste, cream or gel, it may include, but is not limited to, animal oil, vegetable oil, wax, paraffin, starch, tragacanth, cellulose derivatives, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide as a carrier component.
[0181] When the formulation of the above cosmetic composition is a powder or spray, it may include lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder as a carrier component, and in particular, when it is a spray, it may additionally include a propellant such as chlorofluorohydrocarbon, propane / butane or dimethyl ether, but may not be limited thereto.
[0182] When the formulation of the above cosmetic composition is a solution or emulsion, it may include a solvent, a solubilizer or an emulsifier as a carrier component, and may include, but is not limited to, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
[0183] When the formulation of the above cosmetic composition is a suspension, it may include, but is not limited to, a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tragacanth as a carrier component.
[0184] When the formulation of the above cosmetic composition is a surfactant-containing cleansing, the carrier component may include, but is not limited to, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester.
[0185] As an example of the above cosmetic composition formulation, skin care products including emollient toner, astringent toner, nourishing toner, lotion, gel, cream, essence, eye essence, eye cream, nourishing cream, massage cream, clay pack, and mask pack, makeup products including lipstick, lip tint, lip gloss, lip pencil, eye shadow, foundation, powder, concealer, eyeliner, eye shadow, and mascara, eye remover, makeup remover, cleansing foam, cleansing cream, cleansing oil, cleansing water, hand sanitizer, hand wash, hand scrub, body wash, body scrub, shaving lotion, soap, and wet tissue, cleaning products including body lotion, body oil, body mist, body essence, hand cream, foot cream, and wax-type hair removal agent, infant cosmetics including baby lotion, baby cream, and diaper rash cream, sunscreen, and sun stick, Sun care products including sun sprays and artificial tanning products, hair products including shampoos, rinses, hair conditioner creams, hair styling gels, foams, hair mousses, hair sprays, styling lotions, styling creams, hair essences, hair dyes, hair bleaching creams, and curl activator gels, nail care products including nail polishes, nail polishes, cuticle removers, and cuticle creams, toothpastes, mouthwashes, mouth rinses, mouth films, and personal care products including gums, perfumes, plant extracts, deodorants, and antiperspirant formulations.
[0186] The above composition may be a composition for external application to the skin.
[0187] The above-mentioned external skin composition may be a cream, gel, ointment, skin emulsifier, skin suspension, transdermal delivery patch, drug-containing bandage, lotion, or a combination thereof. The external skin composition according to each formulation can be appropriately selected and blended by those skilled in the art according to the formulation or intended use of other external skin compositions, in addition to the composition of the present invention, without difficulty. In this case, a synergistic effect may occur when applied simultaneously with other raw materials.
[0188] The above skin external preparation may be appropriately mixed with ingredients commonly used in skin external preparations such as cosmetics or medicines, such as aqueous ingredients, oily ingredients, powder ingredients, alcohols, moisturizers, thickeners, ultraviolet absorbers, whitening agents, preservatives, antioxidants, surfactants, fragrances, colorants, various skin nutrients, or combinations thereof, as needed.
[0189] The above skin external preparation may also appropriately contain metal sequestrants such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, and gluconic acid; caffeine, tannin, bellapamil, licorice extract, glabridin, hot water extract of the fruit of Kalin; various herbal medicines; tocopheryl acetate, glycyrrhizic acid, tranexamic acid and derivatives or salts thereof; and sugars such as vitamin C, magnesium ascorbic acid phosphate, ascorbic acid glucoside, arbutin, kojic acid, glucose, fructose, and trehalose.
[0190] It has been confirmed that the cosmetic composition according to the present invention can effectively improve skin conditions such as skin moisturizing, skin aging improvement, skin barrier strengthening, skin wrinkle improvement, skin elasticity enhancement, skin texture improvement, skin transparency enhancement, skin blemish removal, skin whitening, and skin regeneration. Therefore, the cosmetic composition according to the present invention can be usefully utilized as a cosmetic composition for improving skin conditions and used as a new cosmetic product.
[0191] In addition, it was confirmed that the cosmetic composition according to the present invention can effectively improve skin condition by suppressing the expression of inflammatory cytokines such as IL-6 and IL-8, thereby alleviating inflammation. Therefore, it can be usefully utilized as a cosmetic composition for improving skin condition and used as a new cosmetic.
[0192] Furthermore, it was confirmed that the composition of the present invention can effectively and completely dissolve cell culture medium components and albumin without residue by adding a solubility enhancer. Therefore, the composition can be applied to a variety of product groups, such as skin products, lotions, essences, creams, and packs, through the above-described solubility improvement.
[0193] In addition, the present invention relates to a water-in-oil cosmetic composition for improving skin, which contains a cell culture medium and albumin. The cosmetic composition of the present invention provides stability of the formulation while containing a cell culture medium and albumin, and thus can be usefully used as a water-in-oil cosmetic composition for improving skin, which can be spread smoothly and provide a feeling of nutrition without being sticky after absorption.
[0194] In addition, the present invention relates to a water-in-oil type skin improvement cosmetic composition containing a cell culture medium and albumin, and the cosmetic composition of the present invention provides stability of the formulation while containing a cell culture medium and albumin, so that it can be usefully used as a skin improvement cosmetic composition that can be smoothly spread and provide a feeling of nutrition without being sticky after absorption.
[0195] Furthermore, the present invention introduces a spray-drying process to manufacture a powder containing cell culture medium and albumin impregnated into a porous polymer. This has the advantage of enabling even impregnation of the surface and interior of a spherical porous polymer in a single process, while eliminating the use of skin-irritating emulsifiers. Furthermore, by impregnating an effective ingredient with a non-uniform specific gravity and crystal form into the interior and exterior of a spherical porous polymer, homogeneity is improved, thereby eliminating variations in raw material content and composition.
[0196] Figure 1 is a drawing showing the results of confirming the inhibitory effect of SPM on IL-6, an immune / inflammatory factor.
[0197] Figure 2 is a drawing showing the results of confirming the inhibitory effect of IL-8, an immune / inflammatory factor of SPM.
[0198] Figure 3 is a drawing showing a scanning electron microscope image of a composition containing a powder-state cell culture medium and albumin.
[0199] Figure 4 is a drawing showing a scanning electron microscope image of PMMA, a porous polymer powder.
[0200] Figure 5 is a drawing showing a scanning electron microscope image of PMMA impregnated with cell culture medium and albumin components.
[0201] The following examples are provided for more detailed explanation. However, these examples are provided for illustrative purposes only and the scope of the present invention is not limited to these examples.
[0202]
[0203] Manufacturing Example 1: Manufacturing of a composition containing cell culture medium and albumin
[0204] The components of the cell culture medium and albumin described in Table 1 below were sufficiently dissolved in a solvent (e.g., purified water, etc.) to confirm that all components were dissolved, and then filtered through a 0.2 ㎛ filter to prepare a mixed composition containing the following 23 components. Each component described in Table 1 below was purchased from Sigma-Aldrich (USA), and the combination of the 23 components described in Table 1 below is hereinafter referred to as 'SPM'.
[0205] Meanwhile, the concentrations listed in Table 1 refer to the final concentrations in the solution when the above components are completely dissolved in the solvent.
[0206] Ingredient Concentration (g / L) Glycine 0.01875 L-alanine 0.00445 L-arginine hydrochloride 0.1475 L-cysteine hydrochloride-monohydrate-H2O 0.01756 L-glutamine 0.365 L-histidine hydrochloride-monohydrate 0.03148 L-lysine hydrochloride 0.09125 L-methionine 0.01724 L-proline 0.01725 L-serine (L-serine) 0.02625 L-threonine 0.05345 L-valine 0.05285 i-inositol 0.0126 Thiamine hydrochloride 0.00217 Niacinamide 0.00202 Pyridoxine hydrochloride 0.002 Sodium chloride (NaCl) 3.49775 Sodium bicarbonate (NaHCO3) 2.438 Potassium chloride (KCl) 0.3118 Calcium chloride (CaCl2) (anhydrous) 0.1166 Sodium phosphate monobasic monohydrate, NaH2PO4-H2O)0.0625sodium pyruvate0.055albumin0.1
[0207]
[0208] Experimental Example 1: Confirmation of skin condition improvement effect
[0209] 1-1. Preparation of a cosmetic composition containing cell culture medium and albumin
[0210] After weighing each raw material in a beaker according to the composition and content (weight %) of the stone described in Table 2 below, the mixture was uniformly mixed at room temperature using a disper at 1000 rpm for 30 minutes.
[0211] Example 1 Comparative Example 1 Purified water 64.00 64.76 SPM 0.76 - Citric acid 0.04 0.04 Sodium citrate 0.01 0.01 Sodium hyaluronate 0.10 0.10 Betaine 1.00 1.00 Niacinamide 2.00 2.00 Adenosine 0.04 0.04 Propanediol 5.00 5.00 Glycerin 15.00 15.00 Butylene glycol 10.00 10.00 1,2-hexanediol 2.00 2.00 Ethylhexylglycerin 0.05 0.05
[0212]
[0213] 1-2. Evaluation of skin texture improvement efficacy
[0214] In order to evaluate the skin texture improvement effect of the composition containing SPM manufactured in Experimental Example 1-1, the following experiment was performed.
[0215] Specifically, 20 female panelists aged 20 to 59 were asked to use the test product on their faces for 4 weeks (twice a day). Before the device measurement, they washed their faces and waited for 30 minutes under constant temperature and humidity conditions (20-24℃, 45-55% RH). Device measurements were conducted before, 2 weeks after, and 4 weeks after product use.
[0216] Skin texture was measured once on the test and control areas (cheeks) using the Antera 3D CS (Miravex, Ireland), and the average roughness (Ra) was used as the evaluation data. The measuring device uses light-emitting diodes (LEDs) to measure the skin surface image. Data can be extracted from the built-in program's 3D shape image, quantifying skin condition, and utilizing the image. A decrease in the skin roughness measurement value (Ra) indicates an improvement in skin texture.
[0217] As a result of measuring skin texture after 4 weeks of use of Example 1 containing the above SPM and Comparative Example 1 not containing SPM as a control group, it was confirmed that the product containing SPM as an active ingredient had an excellent effect in improving skin texture. (Table 3).
[0218] Skin texture measurement results Test area Control area Skin texture measurement value (Ra) Before use (A) 6.530±1.81 26.528±1.80 7 After 2 weeks of use (B) 6.142±1.72 46.341±1.76 8 After 4 weeks of use (C) 5.788±1.63 06.094±1.69 1 Change after 2 weeks of use (BA) - 0.388 - 0.187 Change after 4 weeks of use (CA) - 0.742 - 0.434
[0219] Based on the above results, it was confirmed that the composition containing SPM (a mixture of cell culture medium components and albumin) improved skin texture by reducing roughness.
[0220]
[0221] 1-3. Evaluation of skin transparency improvement efficacy
[0222] In order to evaluate the skin transparency improvement efficacy of the composition containing the SPM manufactured in Experimental Example 1-1 above, the following experiment was performed.
[0223] Specifically, 20 female panelists aged 20 to 59 were asked to use the test product on their faces for 4 weeks (twice a day). Before the device measurement, they washed their faces and waited for 30 minutes under constant temperature and humidity conditions (20-24℃, 45-55% RH). Device measurements were conducted before, 2 weeks after, and 4 weeks after product use.
[0224] Skin transparency was measured once on the test / control area (cheek) using a Translucencymeter (TLS850, Dia-Stron, United Kingdom). The measurement principle is that a thin beam from an RGB LED light source is irradiated onto the skin, and the intensity of the scattered light scattered within the skin is measured using an FOP (Fibre Optic Face Plate). It indicates the rate of decrease in skin penetration light according to distance from the light source, and a decrease in the measured value (Alpah) indicates an improvement in skin transparency.
[0225] As a result of measuring skin transparency after 4 weeks of use of Example 1 containing the above SPM and Comparative Example 1 not containing SPM as a control group, it was confirmed that skin transparency increased in the product containing SPM as an active ingredient. (Table 4).
[0226] Skin transparency measurement results Test area Control area Skin transparency measurement value (alpha) Before use (A) 0.0257±0.0057 0.0255±0.0057 After 2 weeks of use (B) 0.0248±0.0055 0.0249±0.0055 After 4 weeks of use (C) 0.0236±0.0052 0.0245±0.0054 Change after 2 weeks of use (BA) - 0.0009- 0.0006 Change after 4 weeks of use (CA) - 0.0021- 0.0010
[0227] Based on the above results, it was confirmed that skin transparency was improved in the case of a composition containing SPM (a mixture of cell culture medium components and albumin).
[0228]
[0229] 1-4. Skin moisturizing efficacy evaluation
[0230] In order to evaluate the skin moisturizing effect of the composition containing the SPM manufactured in Experimental Example 1-1, the following experiment was performed.
[0231] Specifically, 20 female panelists aged 20 to 59 were asked to use the test product on their faces for 4 weeks (twice a day). Before the device measurement, they washed their faces and waited for 30 minutes under constant temperature and humidity conditions (20-24℃, 45-55% RH). Device measurements were conducted before, 2 weeks after, and 4 weeks after product use.
[0232] Skin hydration was measured using a Corneometer CM825 (Courage Khazaka electronic, Germany) on the test and control areas (cheeks). Measurements were performed three times, and the average value was used as the evaluation data. The measurement principle utilizes capacitance, and the difference in dielectric constant between water and the measured substance is expressed as the measured value. An increase in the measured value (AU) indicates an improvement in skin hydration.
[0233] As a result of measuring skin hydration after 4 weeks of use of Example 1 containing the above SPM and Comparative Example 1 not containing SPM as a control group, it was confirmed that the product containing SPM as an active ingredient had an excellent moisturizing effect. (Table 5).
[0234] Skin Moisture Measurement Results Test Area Control Area Skin Moisture Measurement Value (AU) Before Use (A) 34.773±13.178 35.283±13.571 After 2 Weeks of Use (B) 41.400±14.56 138.507±14.124 After 4 Weeks of Use (C) 46.426±15.320 41.653±14.277 Change after 2 Weeks of Use (BA) 6.627 3.224 Change after 4 Weeks of Use (CA) 11.65 36.37
[0235] Based on the above results, it was confirmed that a composition containing SPM (a mixture of cell culture medium components and albumin) greatly helped moisturize the skin.
[0236]
[0237] 1-5. Evaluation of skin blemish / freckle improvement efficacy
[0238] In order to evaluate the skin blemish / freckle improvement efficacy of the composition containing the SPM manufactured in Experimental Example 1-1 above, the following experiment was performed.
[0239] Specifically, 20 female panelists aged 20 to 59 were asked to use the test product on their faces for 4 weeks (twice a day). Before the device measurement, they washed their faces and waited for 30 minutes under constant temperature and humidity conditions (20-24℃, 45-55% RH). Device measurements were conducted before, 2 weeks after, and 4 weeks after product use.
[0240] Freckle / blemish measurement was performed once on the test area / control area (freckle / blemish area) using Antera 3D CS (Miravex, Ireland), and the affected area (mm) in Melanin-Hyperconcentration analysis mode 2 ) was used as evaluation data. The measurement principle is that it is a device that can measure the surface image of the skin using a light-emitting diode (LED light source), and a 3D shape image was utilized using the built-in program. Measurement value (mm 2 ) means that the freckles / blemishes are improved as they decrease.
[0241] As a result of measuring the area of freckles / blemishes after 4 weeks of use of Example 1 containing the above SPM and Comparative Example 1 not containing SPM as a control group, it was confirmed that the product containing SPM as an active ingredient had an excellent effect in improving freckles / blemishes (Table 6).
[0242] Freckle and blemish area measurement results Test area Control area Freckle and blemish area measurement values (mm) 2 )Before use (A) 36.700±13.998 36.700±13.930 After 2 weeks of use (B) 32.250±12.838 34.450±13.452 After 4 weeks of use (C) 28.450±12.198 31.900±12.998 Change after 2 weeks of use (BA) - 4.45 - 2.25 Change after 4 weeks of use (CA) - 8.25 - 4.8
[0243] Based on the above results, it was confirmed that the composition containing SPM (a mixture of cell culture medium components and albumin) improved the area of freckles / blemishes by reducing them.
[0244]
[0245] 1-6. Evaluation of skin elasticity improvement efficacy
[0246] In order to evaluate the skin elasticity improvement effect of the composition containing SPM manufactured in Experimental Example 1-1, the following experiment was performed.
[0247] Specifically, 20 female panelists aged 20 to 59 were asked to use the test product on their faces for 4 weeks (twice a day). Before the device measurement, they washed their faces and waited for 30 minutes under constant temperature and humidity conditions (20-24℃, 45-55% RH). Device measurements were conducted before, 2 weeks after, and 4 weeks after product use.
[0248] Skin elasticity was measured using Cutometer Dual MPA580 (Courage Khazaka electronic, Germany), and the test area / control area (cheek) was measured once and used as evaluation data. The measurement principle uses negative pressure (450 mbar) and measures the length of the skin pulled by a 2 mm diameter probe using infrared rays. R, a parameter representing the total elasticity of the skin as an overall elasticity value 2 is used as an evaluation index, and R, which is an index for evaluating skin elasticity, is used as an evaluation index. 2 The closer the value is to 1, the better the skin elasticity is.
[0249] As a result of measuring skin elasticity after 4 weeks of use of Example 1 containing the above SPM and Comparative Example 1 not containing SPM as a control group, it was confirmed that the product containing SPM as an active ingredient had an excellent effect in improving skin elasticity. (Table 7).
[0250] Skin elasticity measurement results Test area Control area Skin elasticity measurement value (R 2)Before use0.649±0.1500.646±0.147After 2 weeks of use0.676±0.1560.660±0.150After 4 weeks of use0.696±0.1590.671±0.152Change after 2 weeks of use (BA)0.0270.014Change after 4 weeks of use (CA)0.0470.025
[0251] Based on the above results, it was confirmed that the composition containing SPM (a mixture of cell culture medium components and albumin) improved skin elasticity by increasing it.
[0252]
[0253] Experimental Example 2: Confirmation of the Inflammatory Factor Inhibitory Effect
[0254] 2-1. Confirmation of the effect of suppressing inflammatory factors
[0255] To confirm the anti-inflammatory effect of SPM of the above manufacturing example 1, the expression levels of inflammatory cytokines IL-6 and IL-8 were measured in HaCaT keratinocytes.
[0256] Specifically, HaCaT Keratinocyte cells were suspended in 2 ml of DMEM containing 10% FBS and seeded at 4 × 10 per well. 5 After seeding the cells in 6-well plates, they were cultured at 37°C in 5% CO2 for 24 hours. Afterwards, the samples were added simultaneously while treating with stimulants, Poly IC (10 μg / ml) and IL-4 (10 ng / ml), and cultured at 37°C for 4 hours to induce overexpression of the proinflammatory cytokines IL-6 and IL-8. 1 μM dexamethasone was used as a positive control. After washing with PBS (phosphate-buffered saline), mRNA within the cells was extracted and synthesized into cDNA, and real-time PCR was performed using target templates (primers) to evaluate the expression levels of IL-6 and IL-8.
[0257] As a result, as shown in Figures 1 and 2, the effect of inhibiting the expression of IL-6 and IL-8 was confirmed in the SPM treatment group.
[0258]
[0259] 2-2. Manufacturing of various formulations
[0260] Based on the results of the experimental examples described above, the cell culture medium and albumin-containing cosmetic of the present invention are formulated and presented. However, the composition of the present invention is not intended to be limited to the following formulation examples.
[0261]
[0262] (1) Formulation Example 1: Softening toner (skin lotion)
[0263] A flexible toner formulation containing cell culture medium and albumin was prepared according to a conventional method with the ingredients / contents shown in Table 8 below.
[0264] Ingredient content (weight %): Purified water to 100, Cell culture medium / albumin 0.78, Butylene glycol 4.00, Glycerin 4.00, Hexanediol 1.00, Pentylene glycol 1.00, Propanediol 5.00, Polysorbate 200.60, Ethylhexylglycerin 0.20, Xanthan gum as needed, Fragrance as needed, Citric acid as needed
[0265]
[0266] (2) Formulation Example 2: Nourishing Toner (Milk Lotion)
[0267] A nutritional toner formulation containing cell culture medium and albumin was prepared according to a conventional method with the ingredients / contents shown in Table 9 below.
[0268] Ingredients (weight %): Purified water to 100, Cell culture medium / albumin 0.78, Glycerin 8.00, Butylene glycol 3.00, Hydroxyacetophenone 0.50, Shea butter 2.00, Avocado oil 3.00, Coconut oil 3.00, Coconut butter 1.00, Cetearyl alcohol 1.00, Glyceryl stearate 0.30, Polyglyceryl-3 methyl glucose distearate 1.20, Cetearyl alcohol / Cetearyl glucoside / Glucose 0.60, Hydroxyethyl acrylate / Sodium acryloyldimethyl taurate copolymer 1.00, Caprylyl glycol 0.50, Xanthan gum qq, Citric acid qq, Fragrance qq
[0269]
[0270] (3) Formulation Example 3: Nutritional Essence
[0271] A nutritional essence formulation containing cell culture medium and albumin was prepared according to a conventional method with the ingredients / contents shown in Table 10 below.
[0272] Ingredient content (weight %): Purified water to 100, Cell culture medium / albumin 0.78, Hydroxyacetophenone 0.40, Tromethamine 0.08, Propanediol 5.30, Glycerin 3.00, Panthenol 0.50, Hexanediol 1.20, Methylpropanediol 4.00, Ammonium acryloyldimethyltaurate / VP copolymer 0.30, Carbomer 0.12, Dipropylene glycol 3.00, Polyglyceryl-10 laurate 0.30, Ethylhexylglycerin 0.10, Disodium EDTA q.a., Xanthan gum q.a., Citric acid q.a., Fragrance q.a.
[0273]
[0274] (4) Formulation Example 4: Nourishing Cream
[0275] A nutritional cream formulation containing cell culture medium and albumin was prepared according to a conventional method with the ingredients / contents shown in Table 11 below.
[0276] Ingredients (weight %): Purified water to 100, Cell culture medium / albumin 0.78, Glycerin 2.00, Glycerin 5.00, Hexanediol 1.00, Pentylene glycol 1.00, Glyceryl stearate 0.60, Polyglyceryl-3 methyl glucose distearate 2.00, Cetearyl alcohol / Cetearyl glucoside / Glucose 1.20, Stearyl alcohol / Cetyl alcohol 1.50, Synthetic beeswax 1.00, Stearic acid 0.40, Shea butter 3.00, Caprylic acid / Capric / Myristic / Stearic Triglyceride 2.00 Macadamia Nut Oil 2.00 Hydrogenated Poly(C6-14 Olefin) 3.00 Caprylic / Capric Triglyceride 2.00 Sodium Acrylate / Sodium Acryloyldimethyl Taurate Copolymer 1.00 Ethylhexylglycerin 0.10 Phenoxyethanol 0.30 Citric Acid (as needed) Fragrance (as needed) Disodium EDTA (as needed) Tocopheryl Acetate (as needed)
[0277]
[0278] Experimental Example 3: Preparation and Evaluation of a Composition Containing Cell Culture Medium, Albumin, and a Dissolution Enhancer
[0279] 3-1. Preparation of a composition containing cell culture medium, albumin, and a solubilizing agent
[0280] A composition was prepared by mixing the SPM described in Manufacturing Example 1 and various types of dissolution enhancers into purified water, as described in Table 12 below.
[0281] Example composition ingredients 2 Purified water (100g) + SPM (0.78g) 3 Purified water (100g) + SPM (0.78g) + citric acid (appropriate amount) 4 Purified water (80g) + SPM (0.78g) + DPG (20g) 5 Purified water (100g) + SPM (0.78g) + sodium citrate (appropriate amount) 6 Purified water (100g) + SPM (0.78g) + sodium hydroxide (appropriate amount) 7 Purified water (100g) + SPM (0.78g) + glycolic acid (appropriate amount)
[0282]
[0283] 3-2. Solubility Evaluation
[0284] The solubility of the above Examples 2 to 7 was evaluated. As a result, it was confirmed that complete dissolution without residue was achieved only when citric acid was added as a dissolution enhancer (Table 13).
[0285] Example Solubility enhancer pH Solubility evaluation Completely dissolved Degree of solubility 2-8.58 X Much residue 3 Citric acid 7.56 O No residue 4 DPG 8.65 X Much residue 5 Sodium citrate 8.73 X Little residue 6 Sodium hydroxide 9.47 X Much residue 7 Glycolic acid 2.32 X Little residue
[0286] Based on the above results, it can be seen that the solubility of SPM (a mixture of cell culture medium components and albumin) is improved when citric acid is used as a solubility enhancer or when the pH condition is adjusted to a range of 7 to 8.
[0287]
[0288] Experimental Example 4: Preparation and Evaluation of an Oil-in-Water Cosmetic Composition Containing Cell Culture Medium and Albumin
[0289] 4-1. Preparation of an oil-in-water cosmetic composition containing cell culture medium and albumin
[0290] To prepare an oil-in-water cosmetic composition containing cell culture medium and albumin, the following experiments were performed.
[0291] Specifically, the aqueous phase was adjusted in a beaker according to the content ratio (weight %) shown in Tables 14 and 15 below, and then stirred at 2,500 rpm at 75°C for 5 minutes using a homomixer, and then the thickener part was added and stirred at 6,500 rpm for 5 minutes. Next, the dissolved oil phase was slowly added to the aqueous phase and stirred at 6,500 rpm for 5 minutes, and then the neutralizer part was added and stirred at 6,500 rpm for 3 minutes. Through the cooling process, the active ingredient part was added at 40 to 45°C, mixed at 3,500 rpm for 3 minutes, and finally cooled to 30°C to prepare a cosmetic composition.
[0292] Meanwhile, Table 14 below shows cosmetic compositions prepared according to changes in thickener, and Table 15 below shows cosmetic compositions prepared according to changes in surfactant.
[0293] Product Name Example 8 Example 9 Example 10 Example 11 Example 12 Water Unpurified Water to 100 to 100 to 100 to 100 to 100 Glycerin 5.00 5.00 5.00 5.00 5.00 Xanthan gum - 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.90 0.90 0.90 0.90 0.90 0.90 Polyacrylate crosspolymer-6 - Polyacrylate-13 ㅡㅡ0.90ㅡㅡSodium acrylate / sodium acryloyldimethyl taurate copolymerㅡㅡㅡ0.90ㅡHydroxyethyl acrylate / sodium acryloyldimethyl taurate copolymerㅡㅡㅡㅡ0.90Oil phase Glyceryl stearate SE3.003.003.003.003.00Cetearyl alcohol 1.601.601.601.601 .60 Cetearyl Glucoside 0.400 400 400 400 400 40 Stearic Acid 2.70 2.70 2.70 2.70 2.70 Shea Butter 3.00 3.00 3.00 3.00 3.00 3.00 Coconut Oil 5.00 5.00 5.00 5.00 5.00 Beeswax 0.500 500 500 500 500 500 50 Ethylhexyl Palmitate 7.50 7.507.507.507.50 Caprylic / Capric Triglyceride 3.003.003.003.003.00 Macadamia Nut Oil 1.001.001.001.001.00 Neutralizing Agent Purified Water 5.00ㅡㅡㅡㅡTromethamine 0.80ㅡㅡㅡㅡActive Ingredient Purified Water 10.0010.0010.0010.0010.00 Cell Culture Medium and Albumin (SPM) 0.780.780.780.780.78
[0294]
[0295] Item Name Example 13 Example 14 Example 15 Example 16 Example 17 Water-soluble purified water to 100to 100to 100to 100to 100 Glycerin 5.00 5.00 5.00 5.00 5.00 5.00 Xanthan Gum 0.200 200 200 200 200 20 Phenoxyethanol 0.500 500 500 500 500 500 50 Hexanediol 1.50 ... / C12-20 alkyl glucoside - - - 0.70 - polyglyceryl-3 methyl glucose distearate - - - 2.00 - polyglyceryl-6 stearate / polyglyceryl-6 behenate - - - - 0.50 C12-16 alcohol / palmitic acid / hydrogenated lecithin - - - - 2.00 cetearyl alcohol 1.60 1.60 1.60 1.60 1.60 1.60 stearic acid 2.70 2.70 2.70 2.70 2.70 shea butter 3.00 3.00 3.00 3.00 3.00 Coconut oil 5.00 5.00 5.00 5.00 5.00 Beeswax 0.50 0.50 0.50 0.500.50 Ethylhexyl palmitate 7.507.507.507.507.50 Caprylic / Capric Triglyceride 3.003.003.003.003.00 Macadamia Nut Oil 1.001.001.001.001.00 Active Ingredient Purified Water 10.0010.0010.0010.0010.00 Cell Culture Medium and Albumin 0.780.780.780.780.78
[0296]
[0297] 4-2. Stability test of cosmetic formulations according to temperature changes
[0298] In order to confirm the stability of the water-based cosmetic formulation of the present invention according to temperature changes, the following experiment was conducted.
[0299] Specifically, the long-term storage stability of the cosmetic formulations of Examples 8 to 17 was evaluated using the evaluation criteria below in a constant temperature bath of 4°C, 45°C, 50°C, Cycle (-15°C to 45°C), and at room temperature for 1 week, 1 month, and 6 months, and the results are shown in Tables 16 and 17 below (evaluation criteria, stable: ○, unstable: △, separated: ×).
[0300] Temperature Period Example 8 Example 9 Example 10 Example 11 Example 124 ℃ 1 week ○○○○○ 1 month △○○○○ 6 months X ○○○○○ Room temperature 1 week ○○○○○○ 1 month △○○○○ 6 months X ○○○○○ 45 ℃ 1 week △ ○○○○○ 1 month X ○○○○○ 6 months X ○○○○○ 50 ℃ 1 week X ○○○○○ 1 month X ○○○○○ 6 months ㅡㅡㅡㅡㅡ Cycle (-15~45℃) 1 week X ○○○○○ 1 month X △△△△ 6 months ㅡㅡㅡㅡㅡ
[0301] Temperature Period Example 13 Example 14 Example 15 Example 16 Example 174 ℃ 1 week ○○○○○ 1 month △○○○○ 6 months X ○○○○○ Room temperature 1 week ○○○○○○ 1 month △○○○○ 6 months X ○○○○○ 45 ℃ 1 week △ ○○○○○ 1 month X ○○○○○ 6 months X ○○○○○ 50 ℃ 1 week X ○○○○○ 1 month X ○○○○○ 6 months ㅡㅡㅡㅡㅡ Cycle (-15~45℃) 1 week X ○○○○○ 1 month X △△△△ 6 months ㅡㅡㅡㅡㅡ
[0302] As shown in Tables 16 and 17 above, the formulations of Examples 8 and 13, which used polysorbate 60 and sorbitan sesquioleate as surfactants or carbomer as a thickener, were unstable, whereas the formulations of Examples 9 to 12 and Examples 14 to 17, which used different types of surfactants and thickeners, were found to have excellent stability. Based on the above results, it can be seen that there is no problem in stability of the oil-in-water formulation containing the cell culture medium and albumin of the present invention due to the active ingredient of the formulation.
[0303]
[0304] Experimental Example 5: Preparation and Evaluation of a Water-in-Oil Cosmetic Composition Containing Cell Culture Medium and Albumin
[0305] 5-1. Preparation of a water-in-oil cosmetic composition containing cell culture medium and albumin
[0306] To prepare a water-in-oil type cosmetic composition containing cell culture medium and albumin, the following experiments were performed.
[0307] Specifically, the oil phase was adjusted in a beaker according to the content ratios shown in Tables 18 to 20 below, and then stirred at 2,500 rpm at 75°C for 5 minutes using a homomixer to confirm complete dissolution. Next, the dissolved aqueous phase was slowly added to the oil phase while stirring at 6,500 rpm for 5 minutes, and then finally cooled to 30°C to prepare a cosmetic composition.
[0308] Meanwhile, Table 18 below shows a cosmetic composition prepared by changing the surfactant, Table 19 below shows a cosmetic composition prepared by changing the thickener (stabilizer), and Table 20 below shows a cosmetic composition prepared by changing the wax.
[0309] Raw material name Example 18 Example 19 Example 20 Example 21 Example 22 Oil phase Cyclopentasiloxane 7.00 7.00 7.00 7.00 7.00 7.00 Phenyl trimethicone 5.00 5.00 5.00 5.00 5.00 PEG-10 Dimethicone - 3.00 - - - PEG / PPG-18 / 18 Dimethicone - 3.00 - - Cetyl PEG / PPG-10 / 1 Dimethicone - - - 3.00 - Bis-PEG / PPG-14 / 14 Dimethiconeㅡㅡㅡㅡ3.00Hectorite1.001.001.001.001.00Beeswax1.001.001.001.001.00Dimethicone / Vinyl Dimethicone Crosspolymer0.500.500.500.500.500.50Water phase unpurified water to 100to 100to 100to 100cell culture medium and albumin (SPM) 0.78 0.78 0.78 0.78 0.78 Disodium EDTA 0.020 020 020 020 020 02 Glycerin 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Propanediol 5.00 5.00 5.00 5.00 5.00 5.00 Ethylhexylglycerin 0.05 0.05 0.05 0.05 0.05 1,2-Hexanediol 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.50 1.50 1.50 1.50 1.50
[0310] Raw material name Example 23 Example 24 Example 25 Example 26 27 Cyclopentasiloxane 7.007.007.007.007.00 Phenyl Trimethicone 5.005.005.005.005.00 PEG-10 Dimethicone 3.003.003.003.003.00 Hectorite ㅡ 1.00ㅡㅡㅡQuaternium-18 Hectorite ㅡ 1.00ㅡㅡㅡStearalkonium Hectorite ㅡㅡㅡ 1.00ㅡㅡDisteardimonium Hectorite ㅡㅡㅡㅡ 1.00 Beeswax 1.001.001.001.001.00 Dimethicone / Vinyl Dimethicone Crosspolymer 0.500.500.500.500.50 Water Unpurified Water to 100to 100to 100to 100to 100 Cell culture medium and albumin 0.78 0.78 0.78 0.78 Disodium EDTA 0.02 ...
[0311] Raw material name Example 28 Example 29 Example 30 Example 31 Example 32 Oil phase Cyclopentasiloxane 7.00 7.00 7.00 7.00 7.00 7.00 Phenyl trimethicone 5.00 5.00 5.00 5.00 5.00 PEG-10 dimethicone 3.00 3.00 3.00 3.00 3.00 3.00 Hectorite 1.00 1.00 1.00 1.00 1.00 Beeswax - 1.00 - - - Candelilla wax - - 1.00 - - Carnauba wax - - - 1.00 - Ceresin wax - - - - 1.00 Dimethicone / vinyl dimethicone crosspolymer 0.50 0.50 0.50 0.50 0.50 Water phase Unpurified water to 100to 100to 100to 100to 100Cell culture medium and albumin0.780.780.780.780.78Disodium EDTA0.020.020.020.020.02Glycerin5.005.005.005.005.00Propanediol5.005.005.005.005.00Ethylhexylglycerin0.050.050.050.050.051.2Hexanediol1.001.001.001.001.00Pentylene glycol1.501.501.501.501.501.50
[0312]
[0313] 5-2. Stability test of cosmetic formulations according to temperature changes
[0314] In order to confirm the stability of the water-in-oil type cosmetic formulation of the present invention according to temperature change, the following experiment was conducted.
[0315] Specifically, the long-term storage stability of the cosmetic formulations of Examples 18 to 32 was evaluated based on the evaluation criteria below in a constant temperature chamber of 4°C, 45°C, 50°C, Cycle (-15°C to 45°C), and at room temperature for 1 week, 1 month, and 6 months, and the results are shown in Tables 21 to 23 below (evaluation criteria, stable: ○, unstable: △, separated: ×).
[0316] Temperature Period Example 18 Example 19 Example 20 Example 21 Example 224 ℃ 1 week X ○○○○○ 1 month X ○○○○○ 6 months X ○○○○○ Room temperature 1 week X ○○○○○ 1 month X ○○○○○ 6 months X ○○○○○ 45 ℃ 1 week X ○○○○○ 1 month X ○○○○○ 6 months X ○○○○○ 50 ℃ 1 week X ○○○○○ 1 month X ○○○○○ 6 months - - - - - Cycle (-15 ~ 45 ℃) 1 week X ○○○○○ 1 month X ○△△△ 6 months - - - - -
[0317] Temperature Period Example 23 Example 24 Example 25 Example 26 Example 274 ℃ 1 week ○○○○○ 1 month △○○○○ 6 months △○○○○ Room temperature 1 week ○○○○○ 1 month △○○○○ 6 months △○○○○ 45 ℃ 1 week ○○○○○ 1 month △○○○○ 6 months △○○○○ 50 ℃ 1 week △○○○○ 1 month △○○○○ 6 months ㅡㅡㅡㅡㅡCycle (-15~45℃) 1 week △○○○○ 1 month X △△△△ 6 months ㅡㅡㅡㅡㅡ
[0318] Temperature Period Example 28 Example 29 Example 30 Example 31 Example 324 ℃ 1 week ○○○○○ 1 month ○○○○○ 6 months △○○○○ Room temperature 1 week ○○○○○ 1 month ○○○○○ 6 months △○○○○ 45 ℃ 1 week ○○○○○ 1 month △○○○○ 6 months △○○○○ 50 ℃ 1 week ○○○○○ 1 month △○○○○ 6 months ㅡㅡㅡㅡㅡ Cycle (-15~45℃) 1 week △○○○○ 1 month X △△△△ 6 months ㅡㅡㅡㅡㅡ
[0319] As shown in Tables 21 to 23 above, the formulations of Examples 18, 23, and 28 that did not use a surfactant, thickener (stabilizer), or wax were unstable, but the formulations of Examples 19 to 22, Examples 24 to 27, and Examples 29 to 32 were confirmed to have excellent stability. Based on the above results, it can be seen that in the case of the water-in-oil formulation including the cell culture medium and albumin of the present invention, there is no problem in stability due to the active ingredient of the formulation.
[0320]
[0321] Manufacturing Example 2: Manufacturing of a composite powder in which cell culture medium and albumin are impregnated into a porous polymer powder.
[0322] 2-1. Manufacturing method of composite powder
[0323] First, 20 g of powdered cell culture medium and albumin were dissolved in 2000 g of a mixed solvent containing methanol and dichloromethane in a volume ratio of 1.5:8.5. 15 g of PMMA [Poly(Methyl Methacrylate)] powder, a porous polymer, was added to the solution containing the active ingredient and mixed. The mixed solution was placed in a disk-type spray dryer and spray-dried to produce a composite powder in which the cell culture medium and albumin components were impregnated inside and outside of the PMMA. At this time, the constant spray drying was performed under the conditions of an air injection temperature of 95°C, a chamber temperature of 70 to 75°C, a disk rotation speed of 7,500 rpm / min, and a flow rate of 17 kg / h.
[0324]
[0325] 2-2. Evaluation of the homogenization level of composite powders
[0326] To evaluate the homogenization level of the composite powder manufactured above, the following experiment was performed.
[0327] Specifically, 300 g of the composition of Manufacturing Example 1 and the powder of Manufacturing Example 2 were each placed in a 500 ml container, shaken up and down 30 times, and samples were taken from the upper and lower layers to analyze the albumin content.
[0328] The content of the mixed composition ratio of Manufacturing Example 1 was set as 100%, and the analysis was quantified using HPLC (LC-10AVP, Shimadzu, Japan). The extracted solution was filtered through a syringe filter (pore size 0.2 μm) and injected, and lysozyme was separated using a VP-ODS column (4.6 × 250 mm, Shimadzu, Japan). The mobile phase used was a solution containing 0.1% trifluoroacetic acid in acetonitrile and 0.1% trifluoroacetic acid in water in a 1:1 ratio, and the measurement was performed at a detection wavelength of 220 nm using a UV detector (SPD-10A, Shimadzu, Japan).
[0329] As a result of the above analysis, compared to Manufacturing Example 1, in Manufacturing Example 2, in which the cell culture medium and albumin were manufactured in the form of a complex powder, it was confirmed that the level of homogenization was superior as there was no difference in the content of albumin between the upper and lower layers (Table 24).
[0330] Manufacturing Example 1 Manufacturing Example 2 Upper layer 35.20% 99.30% Lower layer 121.30% 99.75%
[0331] Based on the above results, in the case of the composite powder of Manufacturing Example 2, it can be seen that the active ingredients are uniformly impregnated into the polymer powder and are homogenized and distributed regardless of the differences in crystal form, size, and specific gravity of the active ingredients.
[0332]
[0333] 2-3. Scanning electron microscope (SEM) image
[0334] In order to observe the morphology of the composite powder manufactured above, the following experiment was performed.
[0335] Specifically, the composition of Manufacturing Example 1, the powder of Manufacturing Example 2, and the porous polymer powder PMMA were observed using a scanning electron microscope (SEM).
[0336] As a result, it was confirmed that effective ingredients of various shapes and sizes could be uniformly impregnated into the polymer powder to exhibit a consistent size and shape (Figs. 3 to 5).
[0337]
[0338] The foregoing description of the present invention is provided for illustrative purposes only. Those skilled in the art will readily appreciate that the present invention can be readily modified into other specific forms without altering the technical spirit or essential characteristics of the present invention. Therefore, the embodiments described above should be understood as illustrative in all respects and not restrictive.
Claims
1. A cosmetic composition comprising a cell culture medium and albumin as active ingredients.
2. In claim 1, the cell culture medium contains amino acid components, vitamin components, inorganic salt components, and other components. The amino acid component comprises 0.2 to 1.2 parts by weight of glycine, 0.08 to 0.3 parts by weight of L-alanine, 2 to 7 parts by weight of L-arginine hydrochloride, 0.2 to 0.9 parts by weight of L-cysteine hydrochloride-monohydrate, 10 to 18 parts by weight of L-glutamine, 0.8 to 2.0 parts by weight of L-histidine hydrochloride-monohydrate, 1.0 to 5.0 parts by weight of L-lysine hydrochloride, 0.2 to 1.2 parts by weight of L-methionine, 0.2 to 1.2 parts by weight of L-proline, 1 part by weight of L-serine, 1.0 to 5.0 parts by weight of L-threonine, and 1.0 to 5.0 parts by weight of L-valine, based on 1 part by weight of the amino acid serine. The above vitamin ingredients include i-inositol, thiamine hydrochloride, niacinamide and pyridoxine hydrochloride. The above inorganic salt components include sodium chloride (NaCl), sodium bicarbonate (NaHCO3), potassium chloride (KCl), calcium chloride (CaCl2) (anhydrous), and sodium biphosphate monohydrate (NaH2PO4-H2O). A composition wherein the above other ingredients include sodium pyruvate.
3. A composition according to claim 2, wherein the vitamin component comprises 0.2 to 0.9 parts by weight of i-inositol, 0.04 to 0.8 parts by weight of thiamine hydrochloride, 0.04 to 0.8 parts by weight of niacinamide, and 0.04 to 0.8 parts by weight of pyridoxine hydrochloride based on 1 part by weight of amino acid serine.
4. In claim 2, the inorganic salt component comprises 50 to 200 parts by weight of sodium chloride (NaCl), 50 to 120 parts by weight of sodium bicarbonate (NaHCO3), 2.0 to 20 parts by weight of potassium chloride (KCl), 1.0 to 10 parts by weight of calcium chloride (CaCl2) (anhydrous), and 0.5 to 5.0 parts by weight of sodium biphosphate monohydrate (NaH2PO) based on 1 part by weight of amino acid serine. 4- A composition comprising H2O).
5. A composition according to claim 2, wherein the other component comprises 0.5 to 5.0 parts by weight of sodium pyruvate based on 1 part by weight of amino acid serine.
6. A composition according to claim 1, wherein the albumin is human serum albumin or bovine serum albumin.
7. A composition according to claim 1, wherein the albumin is 10 to 1000 μg / ml.
8. A composition according to claim 1, wherein the composition is for improving skin condition.
9. A composition according to claim 8, wherein the improvement in skin condition includes at least one selected from the group consisting of skin moisturizing, skin aging improvement, skin barrier strengthening, skin wrinkle improvement, skin elasticity enhancement, skin texture improvement, skin transparency enhancement, skin blemish removal, skin whitening, and skin regeneration.
10. A composition for external application to the skin, comprising a cell culture medium and albumin as active ingredients.
11. A composition according to claim 1, wherein the composition is for anti-inflammatory purposes.
12. In claim 11, the composition exhibits at least one of the following properties: 1) Improvement or relief of skin inflammation 2) Skin soothing; and 3) Improvement or prevention of dermatitis.
13. A composition according to claim 12, wherein the dermatitis comprises at least one selected from the group consisting of atopic dermatitis, allergic dermatitis, eczema, contact dermatitis, erythema, and psoriasis.
14. A composition according to claim 11, wherein the composition inhibits the production, activity or expression of inflammatory cytokines.
15. A composition according to claim 14, wherein the inflammatory cytokine comprises at least one selected from the group consisting of TNF-α, IL-1β, IL-4, IL-6, IL-8, IL-9, and IL-13.
16. A composition according to claim 10, wherein the composition is for anti-inflammatory purposes.
17. A composition according to claim 1, wherein the composition additionally comprises a dissolution enhancer.
18. A composition according to claim 17, wherein the dissolution enhancer comprises a pH adjuster.
19. A composition according to claim 18, wherein the pH adjusting agent reduces the pH of the composition.
20. A composition according to claim 17, wherein the pH of the composition is 3.0 to 9.
0.
21. A composition according to claim 17, wherein the pH of the composition is 6.0 to 8.
0.
22. A composition according to claim 18, wherein the pH adjusting agent comprises an organic acid or an inorganic acid.
23. In claim 18, the pH adjusting agent is selected from the group consisting of citric acid, salicylic acid, glycolic acid, lactic acid, malic acid, tartaric acid, mandelic acid, polyhydroxy acid (PHA), b-lipohydroxy acid (LHA), oxalic acid, gluconolactone, ascorbic acid, glutamic acid, D-gluconic acid, sulfonic acid, methanesulfonic acid, benzimidazole sulfonic acid, 4-aminobenzoic acid, benzoic acid, sorbic acid, and phenylbenzimidazole sulfonic acid. A composition comprising at least one selected from the group consisting of benzylidene camphor sulfonic acid, terephthalylidene dicamphor sulfonic acid, kojic acid, hyaluronic acid, phosphoric acid, carbonic acid, hydrochloric acid, acetic acid, and formic acid. 24.1) A step of dissolving the components of the cell culture medium and albumin in a solvent; and 2) A step of adding a dissolution promoter to the solution obtained in the above step and mixing it. A method for improving the solubility of a composition comprising a cell culture medium and albumin.
25. A method according to claim 24, wherein the method comprises a step of adjusting the pH of the solution to a range of 3.0 to 9.0 by adding the dissolution enhancer.
26. A method according to claim 25, wherein the method comprises a step of adding the dissolution enhancer to adjust the pH of the solution to a range of 6.0 to 8.
0.
27. A composition according to claim 1, wherein the composition is an oil-in-water (O / W) composition.
28. A cosmetic composition according to claim 27, characterized in that the cell culture medium and albumin are in an amount of 0.0001 to 10 wt% relative to the total weight of the composition.
29. A composition according to claim 27, wherein the composition further comprises at least one selected from the group consisting of a surfactant, a wax, a butter, a thickener, a higher alcohol, and a higher fatty acid.
30. In claim 29, the surfactant comprises at least one selected from the group consisting of glyceryl stearate SE, cetearyl alcohol, cetearyl glucoside, glyceryl stearate, PEG-100 stearate, glyceryl stearate / PEG-100 stearate, C14-22 alcohol, C12-20 alkyl glucoside, C14-22 alcohol / C12-20 alkyl glucoside, polyglyceryl-3 methyl glucose distearate, polyglyceryl-6 stearate, polyglyceryl-6 behenate, polyglyceryl-6 stearate / polyglyceryl-6 behenate, C12-16 alcohol, palmitic acid, hydrogenated lecithin, and C2-16 alcohol / palmitic acid / hydrogenated lecithin. It is a composition.
31. A composition according to claim 29, wherein the wax comprises at least one selected from the group consisting of beeswax, candelilla wax, carnauba wax, multiwax, paraffin wax, microcrystal wax, and ceresin wax.
32. A composition according to claim 29, wherein the butter comprises at least one selected from the group consisting of shea butter, mango seed butter, cocoa seed butter, cupuacu seed butter, palm seed butter, triciriaimetica seed butter, kokum seed butter, Borneo tallow seed butter, and salicinus seed butter.
33. A composition according to claim 29, wherein the thickener comprises at least one selected from the group consisting of guar gum, carrageenan, xanthan gum, carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, polyacrylate-13, polyacrylate crosspolymer-6, polyacrylamide, sodium acrylate / sodium acryloyldimethyltaurate copolymer, and hydroxyethyl acrylate / sodium acryloyldimethyltaurate copolymer.
34. A composition according to claim 29, wherein the higher alcohol comprises at least one selected from the group consisting of cetyl alcohol, stearyl alcohol, behenyl alcohol, and batyl alcohol.
35. A composition according to claim 29, wherein the higher fatty acid comprises at least one selected from the group consisting of stearic acid, isostearic acid, myristic acid, and palmitic acid.
36. A composition according to claim 10, wherein the composition is an aqueous composition.
37. A composition according to claim 1, wherein the composition is a water-in-oil (W / O) type.
38. A cosmetic composition according to claim 37, characterized in that the cell culture medium and albumin are in an amount of 0.0001 to 10 wt% relative to the total weight of the composition.
39. A composition according to claim 37, wherein the composition further comprises at least one selected from the group consisting of a surfactant, a wax, a butter, a thickener, a higher alcohol, and a higher fatty acid.
40. In claim 39, the surfactant is selected from the group consisting of PEG-8 dimethicone, PEG-9 polydimethylsiloxyethyl dimethicone, PEG-10 dimethicone, PEG-12 dimethicone, PEG-11 methyl ether dimethicone, cetyl PEG / PPG dimethicone, cetyl PEG / PPG-10 / 1 dimethicone, bis-PEG / PPG-14 / 14 dimethicone, bis-PEG / PPG-20 / 20 dimethicone, PEG / PPG-18 / 18 dimethicone, PEG / PPG-19 / 19 dimethicone, PEG / PPG-20 / 20 dimethicone, polyglyceryl-3 polydimethylsiloxyethyl dimethicone, lauryl polyglyceryl-3 polydimethylsiloxyethyl dimethicone, and A composition comprising at least one selected from the group consisting of lauryl PEG-9 polydimethylsiloxyethyl dimethicone.
41. A composition according to claim 39, wherein the wax comprises at least one selected from the group consisting of beeswax, candelilla wax, carnauba wax, multiwax, paraffin wax, microcrystal wax, and ceresin wax.
42. A composition according to claim 39, wherein the thickener comprises at least one selected from the group consisting of hectorite, quaternium-18 hectorite, stearalkonium hectorite, and disteardimonium hectorite.
43. A composition according to claim 39, wherein the butter comprises at least one selected from the group consisting of shea butter, mango seed butter, cocoa seed butter, cupuacu seed butter, palm seed butter, triciriaimetica seed butter, kokum seed butter, Borneo tallow seed butter, and sala seed butter.
44. A composition according to claim 39, wherein the higher alcohol comprises at least one selected from the group consisting of cetyl alcohol, stearyl alcohol, behenyl alcohol, and batyl alcohol.
45. A composition according to claim 39, wherein the higher fatty acid comprises at least one selected from the group consisting of stearic acid, isostearic acid, myristic acid, and palmitic acid.
46. A composition according to claim 10, wherein the composition is a water-in-oil type.
47. A composite powder comprising a cell culture medium, albumin, and a porous polymer.
48. In claim 47, the cell culture medium contains amino acid components, vitamin components, inorganic salt components, and other components, The amino acid component comprises 0.2 to 1.2 parts by weight of glycine, 0.08 to 0.3 parts by weight of L-alanine, 2 to 7 parts by weight of L-arginine hydrochloride, 0.2 to 0.9 parts by weight of L-cysteine hydrochloride-monohydrate, 10 to 18 parts by weight of L-glutamine, 0.8 to 2.0 parts by weight of L-histidine hydrochloride-monohydrate, 1.0 to 5.0 parts by weight of L-lysine hydrochloride, 0.2 to 1.2 parts by weight of L-methionine, 0.2 to 1.2 parts by weight of L-proline, 1 part by weight of L-serine, 1.0 to 5.0 parts by weight of L-threonine, and 1.0 to 5.0 parts by weight of L-valine, based on 1 part by weight of the amino acid serine. The above vitamin ingredients include i-inositol, thiamine hydrochloride, niacinamide and pyridoxine hydrochloride. The above inorganic salt components include sodium chloride (NaCl), sodium bicarbonate (NaHCO3), potassium chloride (KCl), calcium chloride (CaCl2) (anhydrous), and sodium biphosphate monohydrate (NaH2PO4-H2O). A complex powder wherein the above other ingredients include sodium pyruvate.
49. A composite powder according to claim 48, wherein the vitamin component comprises 0.2 to 0.9 parts by weight of i-inositol, 0.04 to 0.8 parts by weight of thiamine hydrochloride, 0.04 to 0.8 parts by weight of niacinamide, and 0.04 to 0.8 parts by weight of pyridoxine hydrochloride based on 1 part by weight of amino acid serine.
50. In claim 48, the inorganic salt component comprises 50 to 200 parts by weight of sodium chloride (NaCl), 50 to 120 parts by weight of sodium bicarbonate (NaHCO3), 2.0 to 20 parts by weight of potassium chloride (KCl), 1.0 to 10 parts by weight of calcium chloride (CaCl2) (anhydrous), and 0.5 to 5.0 parts by weight of sodium biphosphate monohydrate (NaH2PO) based on 1 part by weight of amino acid serine. 4- A composite powder containing H2O).
51. A composite powder according to claim 48, wherein the other component comprises 0.5 to 5.0 parts by weight of sodium pyruvate based on 1 part by weight of amino acid serine.
52. A composite powder according to claim 47, wherein the albumin is human serum albumin or bovine serum albumin.
53. A composite powder according to claim 47, wherein the albumin is 10 to 1000 μg / ml.
54. A composite powder according to claim 47, wherein the cell culture medium and albumin are impregnated into the porous polymer.
55. A composite powder according to claim 47, wherein the porous polymer comprises at least one selected from the group consisting of polymethyl methacrylate [PMMA: poly-(methyl methacrylate)], polyvinyl pyrrolidone [PVP: poly-(vinyl pyrrolidone)], polycaprolactone [PCL: poly-(caprolactone)], polymethylsilsesquioxane [PMSQ: polymethylsilsesquioxane], silica, and poly-L-lactic acid [PLLA: Poly-(L-Lactic Acid)]. 56.1) A step of dissolving or dispersing cell culture medium, albumin and porous polymer in a solvent; and 2) Step of spray drying the above solution or dispersion A method for producing a complex powder comprising a cell culture medium and albumin.
57. A manufacturing method according to claim 56, wherein the solvent comprises at least one selected from the group consisting of ethanol, methanol, acetone, and dichloromethane.
58. A manufacturing method according to claim 56, wherein the spray drying step is performed by at least one selected from the group consisting of a disk type spray dryer and a nozzle type spray dryer.
59. A manufacturing method according to claim 56, wherein in the spray drying step, the air inlet temperature of the spray dryer is 80 to 120°C.
60. A manufacturing method according to claim 56, wherein the chamber temperature of the spray dryer in the spray drying step is 60 to 90°C.
61. A composition comprising the composite powder of any one of claims 47 to 55.
62. A composition according to claim 61, wherein the composition is a cosmetic composition or a composition for external application to the skin.
Citation Information
Patent Citations
Methods for culturing skin stem cells and compositions for improving skin conditions using the same
KR1020130061950A
Cell culture media
KR1020160030301A
Pharmaceutical composition for prevention or treatment of skin diseases comprising cell culture medium
KR1020160102959A
Squid Press Apparatus
KR1020230123847A
Porous polymer particles immobilized with charged molecules and method for preparing the same
US20110020225A1
